entity_token,frequency,entity_class
placebo,170,CONTROL
stroke,121,CONDITION
parkinson's disease,99,CONDITION
pd,88,CONDITION
pain,78,CONDITION
schizophrenia,70,CONDITION
multiple sclerosis,47,CONDITION
alzheimer's disease,43,CONDITION
dementia,42,CONDITION
fibromyalgia,42,CONDITION
ms,41,CONDITION
epilepsy,41,CONDITION
obstructive sleep apnea,31,CONDITION
anxiety,29,CONDITION
osa,29,CONDITION
tdcs,29,OTHER
cpap,27,OTHER
migraine,26,CONDITION
ad,25,CONDITION
tumor,24,CONDITION
sci,23,CONDITION
depression,22,CONDITION
carpal tunnel syndrome,21,CONDITION
spinal cord injury,21,CONDITION
exercise,21,PHYSICAL
acupuncture,20,OTHER
melatonin,19,DRUG
mild cognitive impairment,18,CONDITION
cerebral palsy,18,CONDITION
delirium,18,CONDITION
risperidone,17,DRUG
aripiprazole,17,DRUG
fatigue,15,CONDITION
tbi,15,CONDITION
osas,15,CONDITION
spasticity,15,CONDITION
sleep apnea,15,CONDITION
ttm,15,OTHER
rbd,15,CONDITION
vret,15,OTHER
traumatic brain injury,14,CONDITION
dysphagia,14,CONDITION
transcranial direct current stimulation,14,OTHER
chemotherapy,14,DRUG
hd,13,CONDITION
sdb,13,CONDITION
cancer,13,CONDITION
neuropathic pain,13,CONDITION
parkinson disease,13,CONDITION
levodopa,13,DRUG
continuous positive airway pressure,12,OTHER
sham,12,CONTROL
seizures,12,CONDITION
vitamin d,12,DRUG
mci,11,CONDITION
dbs,11,OTHER
neuromuscular electrical stimulation,11,OTHER
chronic stroke,11,CONDITION
topiramate,11,DRUG
freezing of gait,11,CONDITION
parkinson's,11,CONDITION
fms,11,PHYSICAL
dmd,11,CONDITION
dexmedetomidine,10,DRUG
schizophrenic,10,CONDITION
shoulder pain,10,CONDITION
ataxia,10,CONDITION
fog,10,CONDITION
chronic pain,10,CONDITION
cts,10,CONDITION
tms,10,OTHER
midazolam,10,DRUG
cerebral edema,10,CONDITION
donepezil,10,DRUG
tth,10,CONDITION
pbm,10,OTHER
deep brain stimulation,9,OTHER
acquired brain injury,9,CONDITION
obstructive sleep apnea syndrome,9,CONDITION
methylphenidate,9,DRUG
pku,9,CONDITION
alzheimer disease,9,CONDITION
cp,9,CONDITION
tinnitus,9,CONDITION
als,9,CONDITION
bupivacaine,9,DRUG
csvd,9,CONDITION
covid-19,9,CONDITION
emergence delirium,9,CONDITION
severe traumatic brain injury,8,CONDITION
seizure,8,CONDITION
re,8,CONDITION
cab,8,DRUG
rpv,8,DRUG
diabetes,8,CONDITION
repetitive transcranial magnetic stimulation,8,OTHER
rtms,8,OTHER
fragile x syndrome,8,CONDITION
acute ischemic stroke,8,CONDITION
saline,8,CONTROL
fampridine,8,DRUG
lenalidomide,8,DRUG
mi,8,OTHER
whole body vibration,8,OTHER
park visits,8,OTHER
fentanyl,8,DRUG
ischemic stroke,8,CONDITION
itpr,8,OTHER
peripheral neuropathy,7,CONDITION
hemiplegic,7,CONDITION
pept,7,PHYSICAL
metabolic syndrome,7,CONDITION
mitochondrial myopathy,7,CONDITION
icu,7,CONDITION
amyotrophic lateral sclerosis,7,CONDITION
acute stroke,7,CONDITION
cvd,7,CONDITION
morphine,7,DRUG
aerobic exercise,7,PHYSICAL
hearing loss,7,CONDITION
duchenne muscular dystrophy,7,CONDITION
dha,7,DRUG
sevoflurane,7,DRUG
memantine,7,DRUG
headache,7,CONDITION
sarcopenia,7,CONDITION
mild to moderate alzheimer's disease,7,CONDITION
rivastigmine,7,DRUG
avh,7,CONDITION
tak-079,7,DRUG
menacyw conjugate vaccine,7,DRUG
ci,7,DRUG
alpelisib,7,DRUG
trametinib,7,DRUG
ro7034067,7,DRUG
hypertension,6,CONDITION
at,6,CONDITION
rrms,6,CONDITION
cannabis,6,OTHER
cardiovascular disease,6,CONDITION
cognitive rehabilitation,6,OTHER
emergence agitation,6,CONDITION
levetiracetam,6,DRUG
agitation,6,CONDITION
bradykinesia,6,CONDITION
lamotrigine,6,DRUG
niacin,6,DRUG
insomnia,6,CONDITION
phenylketonuria,6,CONDITION
pramipexole,6,DRUG
radiation therapy,6,RADIOTHERAPY
dermatomyositis,6,CONDITION
ropinirole,6,DRUG
propofol,6,DRUG
pregabalin,6,DRUG
gabapentin,6,DRUG
sarcoidosis,6,CONDITION
usual care,6,CONTROL
hypothermia,6,OTHER
nitric oxide,6,DRUG
ambroxol,6,DRUG
perampanel,6,DRUG
spastic cerebral palsy,6,CONDITION
tes,6,CONDITION
post-stroke,6,CONDITION
diabetic peripheral neuropathy,6,CONDITION
blinatumomab,6,DRUG
rasagiline,6,DRUG
electroacupuncture,6,OTHER
sms,6,CONDITION
mst,6,CONTROL
bpsd,6,CONDITION
pots,6,CONDITION
restless legs syndrome,6,CONDITION
mse,6,OTHER
hepatic encephalopathy,6,CONDITION
lead it!,6,OTHER
menactra,6,DRUG
carepath,6,OTHER
concussion,6,CONDITION
nmes,6,OTHER
sdm,6,OTHER
creatine,6,DRUG
nocturia,6,CONDITION
dex,5,DRUG
huntington's disease,5,CONDITION
nf2,5,CONDITION
thc,5,DRUG
hiv-1,5,CONDITION
lorazepam,5,DRUG
electrical stimulation,5,OTHER
exercise training,5,PHYSICAL
essential tremor,5,CONDITION
abc,5,DRUG
dtg/3tc,5,DRUG
hemiplegic cerebral palsy,5,CONDITION
parkinsonism,5,CONDITION
bg00012,5,DRUG
paliperidone,5,DRUG
abi,5,CONDITION
trichotillomania,5,CONDITION
ocd,5,CONDITION
chronic sci,5,CONDITION
act,5,BEHAVIOURAL
mechanical ventilation,5,OTHER
cognitive deficits,5,CONDITION
mk-8931,5,DRUG
cea,5,SURGICAL
lidocaine,5,DRUG
post-operative pain,5,CONDITION
ataluren,5,DRUG
myozyme,5,DRUG
scs,5,OTHER
subacute stroke,5,CONDITION
rtt,5,CONDITION
alendronate,5,DRUG
control,5,CONTROL
uc,5,CONTROL
ketamine,5,DRUG
botulinum toxin,5,DRUG
itbs,5,OTHER
frailty,5,CONDITION
ads-mr,5,CONDITION
dpn,5,CONDITION
valganciclovir,5,DRUG
modafinil,5,DRUG
ect,5,CONTROL
postmenopausal,5,CONDITION
liver resection,5,CONDITION
caffeine,5,DRUG
mt,5,OTHER
epa,5,DRUG
positive airway pressure,5,OTHER
neurotropin,5,DRUG
atrial fibrillation,5,CONDITION
af,5,CONDITION
hyperacusis,5,CONDITION
start,5,OTHER
cogane,5,DRUG
treadmill walking exercise,5,PHYSICAL
sunbrite,5,BEHAVIOURAL
joint laxity,5,CONDITION
shatavari,5,OTHER
cbt,5,BEHAVIOURAL
risdiplam,5,DRUG
cooling,5,OTHER
rad001,4,DRUG
vestibular schwannoma,4,CONDITION
id,4,CONDITION
type 2 diabetes,4,CONDITION
hiv,4,CONDITION
friedreich's ataxia,4,CONDITION
olanzapine,4,DRUG
phototherapy,4,OTHER
rhythmic auditory stimulation,4,OTHER
diazepam,4,DRUG
carbamazepine,4,DRUG
hemiplegia,4,CONDITION
dronabinol,4,DRUG
telemedicine,4,OTHER
cimt,4,PHYSICAL
amantadine,4,DRUG
ataxia-telangiectasia,4,CONDITION
a-t,4,CONDITION
ziprazidone,4,DRUG
relapsing-remitting multiple sclerosis,4,CONDITION
glatiramer acetate,4,DRUG
msa,4,CONDITION
reading disorder,4,CONDITION
hirrem,4,OTHER
cognitive decline,4,CONDITION
standard care,4,CONTROL
rls,4,CONDITION
virtual reality,4,PHYSICAL
vr,4,OTHER
oral appliances,4,OTHER
oral appliance,4,OTHER
radiation,4,RADIOTHERAPY
oxytocin,4,DRUG
headaches,4,CONDITION
postherpetic neuralgia,4,CONDITION
tau,4,CONTROL
paralyzed,4,CONDITION
physical activity,4,OTHER
robotic exoskeleton,4,PHYSICAL
massage therapy,4,OTHER
cognitive impairments,4,CONDITION
moxibustion,4,OTHER
rehabilitation therapy,4,PHYSICAL
etomidate,4,DRUG
intracerebral hemorrhage,4,CONDITION
iph,4,CONDITION
hearing impaired,4,CONDITION
se,4,CONDITION
aquatic therapy,4,PHYSICAL
nabilone,4,DRUG
oxidative stress,4,CONDITION
trigeminal neuralgia,4,CONDITION
fremanezumab,4,DRUG
npc-14,4,DRUG
aphasia,4,CONDITION
heparinization,4,DRUG
transient ischemic attack,4,CONDITION
rett syndrome,4,CONDITION
tpa,4,CONTROL
hf,4,CONDITION
lipoic acid,4,DRUG
esml-social,4,OTHER
esml-ex,4,OTHER
remimazolam,4,DRUG
brain injury,4,CONDITION
prpp,4,BEHAVIOURAL
electroconvulsive therapy,4,CONTROL
radiosurgery,4,RADIOTHERAPY
sudep,4,CONDITION
severe brain injury,4,CONDITION
erector spinae plane block,4,OTHER
espb,4,OTHER
cardiac surgery,4,CONDITION
therapeutic ultrasound,4,OTHER
d-cycloserine,4,DRUG
ragt,4,PHYSICAL
istradefylline,4,DRUG
nivolumab,4,DRUG
down syndrome,4,CONDITION
desflurane,4,DRUG
biofeedback,4,OTHER
excessive daytime sleepiness,4,CONDITION
flunarizine,4,DRUG
episodic migraine,4,CONDITION
fed-f,4,BEHAVIOURAL
autologous stem cell transplantation,4,SURGICAL
myofascial release,4,OTHER
hypotonic hyponatremia,4,CONDITION
lumbosacral radiculopathy,4,CONDITION
gv1001,4,DRUG
bcaas,4,DRUG
carotid artery stenosis,4,CONDITION
inflammation,4,CONDITION
fus,4,OTHER
xp13512,4,DRUG
tap block,4,OTHER
bci,4,OTHER
asp6981,4,DRUG
generalized myasthenia gravis,4,CONDITION
hmb,4,DRUG
pap,4,OTHER
postoperative cognitive disorders,4,CONDITION
aat,4,OTHER
bright light,4,OTHER
pids,4,CONDITION
c-mill training,4,PHYSICAL
dry needling,4,OTHER
dsp,4,CONDITION
pv,4,PHYSICAL
sibutramine,4,DRUG
sleepiness,4,CONDITION
quetiapine fumarate,4,DRUG
entonox,4,DRUG
aab-003,4,DRUG
clinical pharmacy specialists,4,OTHER
p1g10,4,DRUG
disruptive behavior,4,CONDITION
arterial hypotension,4,CONDITION
computerized attention training,3,BEHAVIOURAL
anorexia nervosa,3,CONDITION
htlv-1,3,CONDITION
asymptomatic carotid artery stenosis,3,CONDITION
cervical mobilization,3,PHYSICAL
tumors,3,CONDITION
estriol,3,DRUG
imovax polio,3,DRUG
cbd,3,DRUG
intellectual disabilities,3,CONDITION
stress,3,CONDITION
st,3,OTHER
sensors technology,3,OTHER
haloperidol,3,DRUG
trns,3,OTHER
schizoaffective disorder,3,CONDITION
dystonia,3,CONDITION
ras,3,OTHER
mandibular advancement device,3,OTHER
mad,3,OTHER
meningiomas,3,CONDITION
subacromial injection,3,OTHER
pea,3,DRUG
sta-1 capsule,3,OTHER
constraint induced movement therapy,3,PHYSICAL
parkinson,3,CONDITION
a-t.,3,CONDITION
physical therapy,3,PHYSICAL
clonidine,3,DRUG
tourette syndrome,3,CONDITION
vitamin b12,3,DRUG
diabetes mellitus,3,CONDITION
amisulpride,3,DRUG
aeds,3,DRUG
aed,3,DRUG
preterm,3,CONDITION
hyperactivity disorder,3,CONDITION
adhd,3,CONDITION
protein substitute,3,OTHER
post-traumatic headache,3,CONDITION
lanreotide,3,DRUG
incomplete spinal cord injury,3,CONDITION
psp,3,CONDITION
acute ischaemic stroke,3,CONDITION
asd,3,CONDITION
high-quality pre-operative videos,3,OTHER
hand surgery,3,CONDITION
muscle stiffness,3,CONDITION
eliprodil,3,DRUG
stbi,3,CONDITION
chronic migraine,3,CONDITION
migraine headaches,3,CONDITION
physical exercise,3,PHYSICAL
heart failure,3,CONDITION
baf312,3,DRUG
functional and cognitive decline,3,CONDITION
surgery,3,SURGICAL
nasal surgery,3,CONDITION
targeted temperature management,3,OTHER
didgeridoo,3,OTHER
postoperative pain,3,CONDITION
post surgical pain,3,CONDITION
temozolomide,3,DRUG
botulinum toxin type a,3,DRUG
partial seizures,3,CONDITION
prader-willi syndrome,3,CONDITION
pws,3,CONDITION
iti,3,OTHER
pompe disease,3,CONDITION
pdvibe2,3,OTHER
epileptic,3,CONDITION
mild alzheimer's disease,3,CONDITION
aggression,3,CONDITION
idd,3,CONDITION
probiotics,3,OTHER
fragile x,3,CONDITION
isolated systolic hypertension,3,CONDITION
theophylline,3,DRUG
dysgeusia,3,CONDITION
fibromyalgia syndrome,3,CONDITION
lbd,3,CONDITION
sleep wake disorders,3,CONDITION
speech-language therapy,3,OTHER
myringotomy tube placement,3,CONDITION
peripheral neuropathic pain,3,CONDITION
balance exercises,3,CONTROL
heparin,3,DRUG
gait training,3,PHYSICAL
pirfenidone,3,DRUG
pa,3,PHYSICAL
cardio exercise program,3,PHYSICAL
csa,3,CONDITION
asv,3,OTHER
oral motor exercises,3,PHYSICAL
breathing exercises,3,PHYSICAL
sustained hypernatremia,3,OTHER
partial-onset seizures,3,CONDITION
eating disorders,3,CONDITION
early stage dementia,3,CONDITION
f-pst,3,BEHAVIOURAL
cognitive challenges,3,CONDITION
duloxetine,3,DRUG
neurodevelopment therapy,3,OTHER
carotid endarterectomy,3,SURGICAL
nmd,3,CONDITION
gpb,3,OTHER
as,3,OTHER
hip surgery,3,CONDITION
hypertonic saline,3,DRUG
saffron,3,OTHER
chamomile,3,OTHER
metformin,3,DRUG
rcmp,3,OTHER
magic camp,3,OTHER
dlpfc,3,OTHER
dcs,3,DRUG
mental retardation,3,CONDITION
autism spectrum disorder,3,CONDITION
hearing-impaired,3,CONDITION
asymptomatic ccmv,3,CONDITION
sleep disordered breathing,3,CONDITION
cfs,3,CONDITION
menthol,3,DRUG
carbon-dioxide,3,DRUG
vbi,3,CONDITION
tevar,3,CONDITION
bf2.649,3,DRUG
pitolisant,3,DRUG
eds,3,CONDITION
spinraza,3,DRUG
gonb,3,SURGICAL
isotretinoin,3,DRUG
sms intervention,3,OTHER
empagliflozin,3,DRUG
parkinsonian,3,CONDITION
anakinra,3,DRUG
acute episode,3,CONDITION
bcaa,3,DRUG
zolpidem,3,DRUG
median nerve stimulation,3,OTHER
severe dementia,3,CONDITION
calcium,3,DRUG
pda-002,3,SURGICAL
esmolol,3,DRUG
idiopathic parkinson's disease,3,CONDITION
mild and moderate hepatic impairment,3,CONDITION
ghostly app,3,OTHER
actimmune,3,DRUG
liver resection surgery,3,CONDITION
brain computer interface,3,OTHER
hip fracture surgery,3,CONDITION
mt-mse,3,OTHER
warm acupuncture,3,OTHER
cognitive remediation,3,BEHAVIOURAL
conventional gait training,3,CONTROL
fshd,3,CONDITION
ctbs,3,OTHER
cerebellar stimulation,3,OTHER
st101,3,DRUG
aricept,3,DRUG
xanamem,3,DRUG
optic neuritis,3,CONDITION
asld,3,CONDITION
golytely,3,DRUG
rituximab,3,DRUG
exchange transfusion,3,OTHER
steroid,3,DRUG
compression garments,3,OTHER
tacs,3,OTHER
dementias,3,CONDITION
nipocalimab,3,DRUG
cerebellar ataxia,3,CONDITION
ctdcs,3,OTHER
acrophobia,3,CONDITION
cbs,3,CONDITION
dysmenorrhea,3,CONDITION
cpp,3,CONDITION
cvt-427,3,DRUG
n-acetyl-l-leucine,3,DRUG
ib1001,3,DRUG
mnd,3,CONDITION
tachosil,3,OTHER
acu,3,OTHER
moxa,3,OTHER
tia,3,CONDITION
moderate to severe dementia,3,CONDITION
22q11.2ds,3,CONDITION
motor imagery,3,OTHER
arterial stiffness,3,CONDITION
obese,3,CONDITION
telephone support,3,BEHAVIOURAL
sam-531,3,DRUG
paf,3,CONDITION
hg,3,CONDITION
head-mounted display,3,OTHER
immersive virtual reality,3,OTHER
taps,3,OTHER
exotropia,3,CONDITION
masitinib,3,DRUG
carbetocin,3,DRUG
lv-101,3,DRUG
pf-05236812,3,DRUG
deficit syndrome,3,CONDITION
gaa,3,DRUG
pf-03654746,3,DRUG
tourette's syndrome,3,CONDITION
primary parkinsonian pain,3,CONDITION
neurologic music therapy,3,OTHER
nmt,3,OTHER
post-spinal headache,3,CONDITION
vasospasm,3,CONDITION
shatavari supplementation,3,OTHER
encephalitis,3,CONDITION
cere-120,3,OTHER
blz-100,3,DRUG
home mechanical ventilation,3,OTHER
tavns,3,OTHER
tnk,3,DRUG
an,2,CONDITION
ham/tsp,2,CONDITION
avonex,2,DRUG
hgns,2,OTHER
early induced hypernatremia,2,OTHER
tachycardia,2,CONDITION
clenbuterol,2,DRUG
jzp385,2,DRUG
periodontal disease,2,CONDITION
acas,2,CONDITION
traditional therapy,2,CONTROL
traditional + cervical mobilization,2,PHYSICAL
citalopram,2,DRUG
early hd,2,CONDITION
sleep-disordered breathing,2,CONDITION
adenotonsillectomy,2,SURGICAL
severe blepharoptosis,2,CONDITION
neurofibromatosis type 2,2,CONDITION
acute intermittent hypoxia,2,OTHER
relapsing-remitting ms,2,CONDITION
relapsing remitting multiple sclerosis,2,CONDITION
generalized major motor seizures,2,CONDITION
prep-to-play,2,BEHAVIOURAL
ip program,2,BEHAVIOURAL
small fiber neuropathy,2,CONDITION
gi dysmotility,2,CONDITION
updated sound processor,2,OTHER
arthritis,2,CONDITION
tuberculosis meningitis,2,CONDITION
chemotherapy-induced painful peripheral neuropathy,2,CONDITION
cipn,2,CONDITION
sham stimulation,2,CONTROL
cti-1601,2,DRUG
tryptophan depletion,2,OTHER
septorhinoplasty,2,CONDITION
task-oriented training,2,PHYSICAL
eszopiclone,2,DRUG
risperdal,2,DRUG
consta,2,DRUG
tsc,2,CONDITION
home based walking program,2,PHYSICAL
dbf,2,DRUG
polyphenol,2,DRUG
rolandic epilepsy,2,CONDITION
sleep training,2,BEHAVIOURAL
suprascapular nerve block,2,OTHER
sci -110,2,DRUG
tetrahydrocannabinol,2,DRUG
complex regional pain syndrome type i,2,CONDITION
crps-1,2,CONDITION
crps,2,CONDITION
endovascular treatment,2,CONDITION
intracranial aneurysms,2,CONDITION
hydrocoil,2,OTHER
sodium oxybate,2,DRUG
xyrem,2,DRUG
cabotegravir,2,DRUG
rilpivirine,2,DRUG
integrase inhibitor,2,DRUG
complete spinal cord injury,2,CONDITION
fes,2,OTHER
hcp,2,CONDITION
movement disorder,2,CONDITION
chorea,2,CONDITION
cariprazine,2,DRUG
tic,2,CONDITION
binocular amblyopia,2,CONDITION
early parkinson's disease,2,CONDITION
ziprasidone,2,DRUG
hydrodissection,2,OTHER
antiepileptic drugs,2,DRUG
ga,2,DRUG
falls,2,CONDITION
paliperidone palmitate,2,DRUG
erythropoietin,2,DRUG
multiple system atrophy,2,CONDITION
atomoxetine,2,DRUG
orthostatic hypotension,2,CONDITION
hirrem-sop,2,OTHER
mncc,2,DRUG
bilateral exablate ablation of the pallidothalamic tract,2,OTHER
ptt,2,OTHER
motor complications,2,CONDITION
phenylalanine-free protein substitute,2,OTHER
lucerastat,2,DRUG
fabry disease,2,CONDITION
hearing for learning initiative,2,BEHAVIOURAL
current practice,2,CONTROL
hpdsc,2,SURGICAL
abobotulinumtoxina,2,DRUG
environmental design,2,OTHER
behavioral regulation,2,BEHAVIOURAL
primary restless legs syndrome,2,CONDITION
supplemental inspired oxygen,2,OTHER
frontotemporal dementia,2,CONDITION
collaborative care,2,OTHER
usual neurology care,2,OTHER
rit,2,BEHAVIOURAL
plt,2,CONTROL
acromegaly,2,CONDITION
brain tumor,2,CONDITION
isci,2,CONDITION
sertraline,2,DRUG
desmoteplase,2,DRUG
robotic trainer,2,PHYSICAL
robotic training,2,PHYSICAL
robotic gait training,2,PHYSICAL
social cognition impairment,2,CONDITION
autism spectrum disorders,2,CONDITION
oxt,2,DRUG
hyalase,2,DRUG
"chronic, incomplete spinal cord injury",2,CONDITION
speeded anomia therapy,2,OTHER
chronic post-stroke aphasia,2,CONDITION
motor dysfunction,2,CONDITION
soc,2,CONTROL
fluorescence-guided resection,2,SURGICAL
malignant gliomas,2,CONDITION
5-aminolevulinic acid,2,DRUG
5-ala,2,DRUG
conventional resection,2,CONTROL
treatment as usual,2,CONTROL
lat8881,2,DRUG
wellness and team solutions program,2,OTHER
severe mental illness,2,CONDITION
functional strength training,2,PHYSICAL
zydena,2,DRUG
udenafil,2,DRUG
normal and subcortical vascular cognitive impairment,2,CONDITION
specific manual therapy,2,OTHER
temporomandibular disorder,2,CONDITION
person-centered internet-based health action process,2,OTHER
spa therapy,2,OTHER
tenderness,2,CONDITION
chronic obstructive pulmonary disease,2,CONDITION
calmare,2,OTHER
intensive care unit,2,CONDITION
delirium prevention bundle,2,OTHER
polymyositis,2,CONDITION
anx005,2,DRUG
multimodal individualized intervention,2,OTHER
sch 900800,2,DRUG
l-dopa,2,DRUG
combined occipital and supraorbital transcutaneous nerve stimulation,2,OTHER
dexamethazone,2,DRUG
low-intensity laser,2,OTHER
eswt,2,OTHER
bell's palsy,2,CONDITION
chronic spinal cord injury,2,CONDITION
rehabilitation,2,PHYSICAL
percutaneous electrical nerve stimulation,2,OTHER
requip,2,DRUG
spastic,2,CONDITION
craniotomy surgery,2,CONDITION
somnodent,2,OTHER
herbst appliance,2,OTHER
mild and moderate osa,2,CONDITION
balance,2,CONDITION
proprioceptive neuromuscular facilitation,2,PHYSICAL
intensive motor training,2,PHYSICAL
fixed pressure,2,OTHER
thoracoscopic mitral valve replacement,2,CONDITION
bat4406f,2,DRUG
neuromyelitis optica spectrum disorders,2,CONDITION
renal insufficiency,2,CONDITION
eculizumab,2,DRUG
neuromyelitis optica,2,CONDITION
wid-clz18,2,DRUG
clozaril,2,DRUG
clozapine,2,DRUG
fragile brain,2,CONDITION
sativex,2,DRUG
diabetic neuropathy,2,CONDITION
ich,2,CONDITION
airway collapsibility,2,CONDITION
traditional chinese medicine,2,OTHER
vgh-ad1,2,OTHER
traumatic coma,2,CONDITION
bia 28-6156,2,DRUG
trigger finger release,2,CONDITION
epinephrine,2,DRUG
post operative pain,2,CONDITION
modified autoset device,2,OTHER
autoset device,2,CONTROL
vpap auto,2,CONTROL
topotecan,2,DRUG
botox,2,DRUG
transcranial magnetic stimulation,2,OTHER
dystrophinopathy,2,CONDITION
mind-body interventions,2,OTHER
immune tolerance induction,2,OTHER
deferiprone,2,DRUG
pkan,2,CONDITION
spinal cord stimulation,2,OTHER
intensive cognitive rehabilitation,2,OTHER
ion373,2,DRUG
group acyw135 meningococcal conjugate,2,DRUG
abe,2,CONDITION
assertive community treatment,2,OTHER
transcutaneous tibial nerve stimulation,2,OTHER
chronic low back pain,2,CONDITION
juvenile pilocytic astrocytomas,2,CONDITION
optic nerve pathway gliomas,2,CONDITION
consecutive exotropia,2,CONDITION
docosahexaenoic acid,2,DRUG
severe behavioural problems,2,CONDITION
intellectual and developmental disabilities,2,CONDITION
sbp,2,CONDITION
stroke-in-evolution,2,CONDITION
bun/cr ratio based hydration therapy,2,OTHER
service dogs,2,OTHER
prebiotics,2,OTHER
ascorbic acid,2,DRUG
tocopherol,2,DRUG
fxs,2,CONDITION
antioxidant,2,DRUG
antihypertensive therapy,2,DRUG
surface acoustic wave patch device,2,OTHER
sham device,2,CONTROL
od,2,CONDITION
bright light treatment,2,OTHER
argininosuccinic aciduria,2,CONDITION
asa,2,CONDITION
no,2,DRUG
trust,2,PHYSICAL
serious mental illness,2,CONDITION
lewy body dementia,2,CONDITION
dtpa-hbv-ipv,2,DRUG
hib,2,DRUG
per,2,DRUG
phonak hearing systems,2,OTHER
central nervous system tumors,2,CONDITION
indocyanine green,2,OTHER
pervasive developmental disorders,2,CONDITION
antipsychotic medication,2,DRUG
pdd,2,CONDITION
acetaminophen,2,DRUG
huntington disease,2,CONDITION
intracranial aneurysm,2,CONDITION
alzheimer,2,CONDITION
cpwalker,2,PHYSICAL
actipatch,2,OTHER
aspirin,2,DRUG
clopidogrel,2,DRUG
neurofibromatosis type 1,2,CONDITION
plexiform neurofibromas,2,CONDITION
juvenile myoclonic epilepsy,2,CONDITION
trans-spinal electrical stimulation,2,OTHER
med,2,OTHER
hyperprolactinemia,2,CONDITION
antipsychotic,2,DRUG
injection site erythema,2,CONDITION
eye mask,2,OTHER
earplugs,2,OTHER
intensive care,2,CONDITION
bev,2,DRUG
rgbm,2,CONDITION
rmp,2,PHYSICAL
standard physiotherapy,2,CONTROL
lam-002a,2,DRUG
rt-pa,2,DRUG
amblyopia,2,CONDITION
osahs,2,CONDITION
epilepsia partialis continua,2,CONDITION
epc,2,CONDITION
refractory status epilepticus,2,CONDITION
ziconotide,2,DRUG
paired plié program,2,PHYSICAL
family-based treatment,2,BEHAVIOURAL
ophthalmic surgery,2,CONDITION
benzodiazepines,2,DRUG
brain injuries,2,CONDITION
community rehabilitation,2,BEHAVIOURAL
staggered intervention,2,CONTROL
attention training interventions,2,BEHAVIOURAL
silkworms (bombyx mori l.) pupae extracts,2,OTHER
total hip replacement,2,CONDITION
juvenile primary fibromyalgia syndrome,2,CONDITION
remote ischemic conditioning,2,OTHER
ustekinumab,2,DRUG
lactobacillus plantarum ps128,2,OTHER
glutamine,2,DRUG
breast cancer,2,CONDITION
paclitaxel,2,DRUG
transcranial electric stimulation,2,OTHER
memory impairment,2,CONDITION
early alzheimer's disease,2,CONDITION
emfit mattress monitor dvm-gprs-v2,2,OTHER
air stacking,2,OTHER
glossopharyngeal breathing,2,OTHER
motivational interviewing,2,BEHAVIOURAL
critically ill,2,CONDITION
sleep apnea syndrome,2,CONDITION
positive end expiratory pressure,2,OTHER
thrombolysis,2,OTHER
spontaneous cerebral hemorrhage,2,CONDITION
puncture aspiration,2,SURGICAL
cerebral hemorrhage,2,CONDITION
insulin resistance,2,CONDITION
moderate to severe osa,2,CONDITION
sgs-742,2,DRUG
ssadh deficiency,2,CONDITION
hemiplegic cp,2,CONDITION
depressive,2,CONDITION
non-invasive brain stimulation,2,OTHER
intermittent theta-burst stimulation,2,OTHER
hemiparesis,2,CONDITION
kw-6002,2,DRUG
advanced parkinson's disease,2,CONDITION
b-all,2,CONDITION
supratentorial craniotomy,2,CONDITION
dopaminergic therapy,2,CONDITION
occupational therapy,2,CONTROL
alzt-op1a,2,DRUG
mild to moderate als,2,CONDITION
audiobooks for hearing loss app,2,OTHER
auditory training,2,OTHER
ci and ha users,2,CONDITION
sensory integration therapy on balance and functional mobility,2,PHYSICAL
minor-to moderate-risk noncardiac surgery,2,CONDITION
mencevax acw135 polysaccharide vaccine,2,DRUG
ccmv-infected,2,CONDITION
self-supporting nasopharyngeal airway,2,OTHER
ssnpa,2,OTHER
covid,2,CONDITION
physical frailty,2,CONDITION
open spina bifida,2,CONDITION
partial onset seizures,2,CONDITION
constipation,2,CONDITION
dyssynergic defecation,2,CONDITION
clinically definite multiple sclerosis,2,CONDITION
paroxetine,2,DRUG
recombinant human endostatin,2,DRUG
cognitive dysfunction,2,CONDITION
iacd,2,OTHER
narcolepsy,2,CONDITION
ndx-1017,2,DRUG
sma type ii,2,CONDITION
nusinersen,2,DRUG
ozone,2,DRUG
chemotherapy-induced peripheral neuropathy,2,CONDITION
lidcombe program,2,BEHAVIOURAL
dm199,2,DRUG
lacosamide,2,DRUG
spinal manipulation,2,OTHER
vagus nerve stimulation,2,OTHER
post covid syndrome,2,CONDITION
greater occipital nerve block,2,SURGICAL
galantamine,2,DRUG
recurrent high-grade glioma,2,CONDITION
tension-type headaches,2,CONDITION
screw retained arch bar,2,OTHER
conventional erich's arch bar,2,OTHER
maxillomandibular fixation,2,OTHER
myotonic dystrophy type 1(dm1),2,CONDITION
paravertebral block,2,OTHER
esp block,2,OTHER
rem sleep behavior disorder,2,CONDITION
jardiance,2,DRUG
early pd,2,CONDITION
inclusion body myositis,2,CONDITION
myositis,2,CONDITION
1072nm infrared (ir) phototherapy,2,OTHER
chf 5074,2,DRUG
peripheral sensitization,2,CONDITION
guardian cap,2,OTHER
mns,2,OTHER
magnetic seizure therapy,2,OTHER
caesarean,2,CONDITION
ropivacaine,2,DRUG
auditory cues,2,OTHER
isms,2,OTHER
behavioural disturbances,2,CONDITION
progressive muscle degeneration,2,CONDITION
stepped care,2,BEHAVIOURAL
stepped care model,2,BEHAVIOURAL
intracranial procedures,2,CONDITION
aoc 1001,2,DRUG
myotonic dystrophy type 1,2,CONDITION
dm1,2,CONDITION
ast-726,2,DRUG
ponesimod,2,DRUG
teriflunomide,2,DRUG
relapsing multiple sclerosis,2,CONDITION
neural stem cells,2,SURGICAL
safinamide,2,DRUG
motor fluctuations,2,CONDITION
postural tachycardia syndrome,2,CONDITION
craniotomy,2,CONDITION
eliglustat tartrate,2,DRUG
carbidopa,2,DRUG
strength training,2,PHYSICAL
postoperative agitation,2,CONDITION
hypoglossal acupuncture,2,OTHER
osteopenia,2,CONDITION
focused ultrasound,2,OTHER
delta-9-tetrahydrocannabinol,2,DRUG
advanced cancer,2,CONDITION
fa,2,CONDITION
ldir,2,RADIOTHERAPY
qigong,2,PHYSICAL
physiotherapy,2,PHYSICAL
visceral pain,2,CONDITION
nature-based activities,2,OTHER
3aps,2,DRUG
emotional processing intervention,2,OTHER
protracted opioid withdrawal,2,CONDITION
risk of falls,2,CONDITION
mild-to-moderate hearing loss,2,CONDITION
multisensory environment,2,OTHER
severe and profound intellectual disabilities,2,CONDITION
corticosteroid,2,DRUG
np101,2,DRUG
imitrex,2,DRUG
acute migraine attack,2,CONDITION
protein supplement,2,OTHER
encephalopathy,2,CONDITION
skeletal muscle proteolysis,2,CONDITION
exenatide,2,DRUG
acute brain injury,2,CONDITION
mobilization,2,OTHER
first-ever stroke,2,CONDITION
ndt,2,PHYSICAL
far infrared radiation,2,RADIOTHERAPY
rehabilitation exercises,2,PHYSICAL
rehabilitation exercise,2,PHYSICAL
treatment-resistant schizophrenia,2,CONDITION
cleft lip,2,CONDITION
octagam,2,DRUG
cntnap2 mutation,2,CONDITION
brain safe,2,OTHER
diastat,2,DRUG
orthopedic surgery,2,CONDITION
animal-assisted therapy,2,OTHER
smith-magenis syndrome,2,CONDITION
app,2,OTHER
dance therapy,2,PHYSICAL
modified constraint-induced movement therapy,2,PHYSICAL
argininosuccinate lyase deficiency,2,CONDITION
cryptogenic stroke,2,CONDITION
somatosensory stimulation,2,OTHER
vestibular stimulation,2,OTHER
polyethylene glycol,2,DRUG
lactulose,2,DRUG
psychoeducation session,2,BEHAVIOURAL
polyneuropathy,2,CONDITION
hereditary spastic paraplegia,2,CONDITION
hsp,2,CONDITION
multimorbid,2,CONDITION
mild dementia,2,CONDITION
auditory nerve test system,2,OTHER
ants,2,OTHER
tourette's disorder,2,CONDITION
cerebellar transcranial direct current stimulation,2,OTHER
oxymorphone,2,DRUG
ren-1654,2,DRUG
post-herpetic neuralgia,2,CONDITION
sles,2,CONDITION
strokes,2,CONDITION
intramuscular electrostimulation,2,OTHER
myofascial trigger points,2,CONDITION
chronic inflammatory demyelinating polyneuropathy,2,CONDITION
cidp,2,CONDITION
stx209,2,DRUG
arbaclofen,2,DRUG
balance training,2,PHYSICAL
biodex balance system,2,PHYSICAL
virtual reality exposure therapy,2,OTHER
height avoidance,2,CONDITION
tauopathies,2,CONDITION
ed,2,CONDITION
zolmitriptan,2,DRUG
repetitive head impacts,2,CONDITION
repeated head impacts,2,CONDITION
mp-214,2,DRUG
receiving multiple drugs schizophrenia,2,CONDITION
insulin-like growth factor-1,2,DRUG
iv amantadine,2,DRUG
motor neuron disease,2,CONDITION
prx-03140,2,DRUG
photobiomodulation,2,OTHER
skull base surgery,2,CONDITION
adl5859,2,DRUG
well-established outpatient group therapy,2,CONTROL
chronic tinnitus,2,CONDITION
dementia care training with virtual reality,2,OTHER
postoperative delirium,2,CONDITION
acute sci,2,CONDITION
neuromuscular,2,CONDITION
etoricoxib,2,DRUG
ards,2,CONDITION
wml,2,CONDITION
rimegepant,2,DRUG
rosiglitazone,2,DRUG
art therapy,2,OTHER
aoc 1020,2,DRUG
facioscapulohumeral muscular dystrophy,2,CONDITION
hyperphenylalaninemia,2,CONDITION
magnesium sulfate,2,DRUG
magnesium,2,DRUG
22q11.2 deletion syndrome,2,CONDITION
cte,2,CONDITION
passive vibration,2,PHYSICAL
affitope® pd01a,2,DRUG
guanfacine,2,DRUG
quetiapine,2,DRUG
tst,2,CONTROL
extracorporeal photopheresis,2,OTHER
mind-s,2,BEHAVIOURAL
bright light therapy,2,OTHER
rds,2,CONDITION
blt,2,OTHER
medulloblastoma,2,CONDITION
basimglurant,2,DRUG
tn,2,CONDITION
alectinib,2,DRUG
subcostal anterior quadratus lumborum block,2,SURGICAL
thoracic paravertebral block,2,SURGICAL
laparoscopic nephrectomy surgery,2,CONDITION
bimanual therapy,2,PHYSICAL
unilateral brain injury,2,CONDITION
tv-46000,2,DRUG
paroxysmal atrial fibrillation,2,CONDITION
mild cognitive impairments,2,CONDITION
memory difficulties,2,CONDITION
coiled low-grade aneurysmal subarachnoid hemorrhage,2,CONDITION
significant hemorrhage burden,2,CONDITION
cholinesterase inhibitors,2,DRUG
mih,2,OTHER
starflex® septal closure system,2,OTHER
best medical therapy,2,CONTROL
coronary artery disease,2,CONDITION
cerebral artery stenosis,2,CONDITION
cad,2,CONDITION
cas,2,CONDITION
cabg,2,CONDITION
percutaneous coronary intervention,2,CONDITION
bipolar disorders,2,CONDITION
screening colonoscopy,2,CONDITION
aci-24,2,DRUG
concussion education programs,2,BEHAVIOURAL
stretching-and-toning activities,2,CONTROL
active control,2,CONTROL
homonymous hemianopsia,2,CONDITION
"supervisory neglect, non-accidental trauma, brief intervention, and treatment referral",2,BEHAVIOURAL
igf-1,2,DRUG
btx,2,DRUG
jaw muscle myalgia,2,CONDITION
patient education,2,BEHAVIOURAL
value-based formulary,2,OTHER
ar based neuronavigation system,2,OTHER
conventional navigation system,2,CONTROL
incobotulinum toxin a,2,DRUG
xeomin,2,DRUG
sialorrhea,2,CONDITION
liuwei dihuang pill,2,OTHER
presbycusis,2,CONDITION
shen (kidney)-yin deficiency,2,CONDITION
sonlicromanol,2,DRUG
mitochondrial disease,2,CONDITION
nbi-98854,2,DRUG
tardive dyskinesia,2,CONDITION
home blood pressure cuff,2,OTHER
muscle failure,2,CONDITION
dynapenia,2,CONDITION
t-62,2,DRUG
clevidipine,2,DRUG
subarachnoid hemorrhage,2,CONDITION
lurasidone hcl,2,DRUG
lurasidone,2,DRUG
meningitis,2,CONDITION
ly3056480,2,DRUG
copaxone,2,DRUG
hydrogel,2,CONTROL
cognitive-behavioral therapy,2,BEHAVIOURAL
dnhs,2,OTHER
cva,2,CONDITION
cardiorespiratory exercise,2,PHYSICAL
sham tavns,2,CONTROL
dlb,2,CONDITION
tenecteplase,2,DRUG
vegetative state,2,CONDITION
cat,1,BEHAVIOURAL
eating disorder,1,CONDITION
early htlv-1-associated myelopathy,1,CONDITION
recombinant human interferon beta-1a,1,DRUG
htlv,1,CONDITION
human t cell leukemia virus,1,CONDITION
htlv-1 associated myelopathy,1,CONDITION
ham,1,CONDITION
tropical spastic paraparesis,1,CONDITION
tsp,1,CONDITION
interferon beta,1,DRUG
recombinant interferon beta,1,DRUG
apnex medical™ hypoglossal nerve stimulation,1,OTHER
hypoglossal nerve stimulation,1,OTHER
apnex medical hypoglossal nerve stimulation,1,OTHER
moderate to severe obstructive sleep apnea,1,CONDITION
brain edema,1,CONDITION
normonatremia,1,OTHER
mannitol,1,DRUG
dexmedethomidine,1,DRUG
pituitary tumor removal by transphenoid approach,1,CONDITION
transnasal transsphenoidal (tnts) resection of pituitary tumors,1,CONDITION
α-2 adrenergic receptor agonist,1,DRUG
early and intensive bimanual stimulation,1,OTHER
unilateral cerebral palsy,1,CONDITION
early bimanual stimulation,1,OTHER
late-onset pompe disease and receiving enzyme replacement therapy,1,CONDITION
late-onset pompe disease (lopd) who are treated with enzyme replacement therapy,1,CONDITION
moderate to severe essential tremor,1,CONDITION
moderate to severe et,1,CONDITION
treatment of periodontitis,1,OTHER
mild to moderate cognitive impairment,1,CONDITION
intensive therapy for periodontitis,1,OTHER
muscle strengthening,1,CONTROL
stretching,1,CONTROL
balance and coordination exercises,1,CONTROL
traditional treatment,1,CONTROL
mild huntington's disease,1,CONDITION
serotonin reuptake inhibitor,1,DRUG
ssri,1,DRUG
obstructive sleep-disordered breathing,1,CONDITION
non-surgical treatments,1,OTHER
non-surgical devices designed to improve eye lid opening for patients,1,OTHER
vestibular schwannoma(s),1,CONDITION
neurofibromatosis 2,1,CONDITION
aih,1,OTHER
generalized tonic/clonic seizure,1,CONDITION
vaporized placebo cannabis,1,CONTROL
supported and unsupported implementation strategies,1,BEHAVIOURAL
injury prevention program,1,BEHAVIOURAL
injury prevention (ip) program,1,BEHAVIOURAL
injuries,1,CONDITION
gastrointestinal motility disorders,1,CONDITION
refractory gastrointestinal motility disorders,1,CONDITION
enteric neuropathy,1,CONDITION
updated bone-anchored sound processor,1,OTHER
ce marked ponto 3 superpower sound processor,1,CONTROL
resistance training program,1,PHYSICAL
disabled intellectual,1,CONDITION
resistance exercise,1,PHYSICAL
tnf inhibitors,1,DRUG
adalimumab,1,DRUG
scrambler therapy,1,OTHER
cerebellar rtms theta burst,1,OTHER
theta burst cerebellar stimulation,1,OTHER
cerebellar theta burst stimulation,1,OTHER
acute agitation,1,CONDITION
acute agitated,1,CONDITION
low level laser therapy,1,OTHER
nemes,1,OTHER
muscle strength and jump training program,1,PHYSICAL
training,1,PHYSICAL
strength and jump training,1,PHYSICAL
sensorimotor impairment,1,CONDITION
ames,1,PHYSICAL
assisted movement with enhanced sensation,1,PHYSICAL
incomplete spinal cord injuries,1,CONDITION
transcranial random noise stimulation,1,OTHER
computerized cognitive rehabilitation therapy,1,OTHER
acquired brain damage,1,CONDITION
cognitive training,1,OTHER
sham trns,1,CONTROL
dual transcranial direct current stimulation (dtdcs)-enhanced therapy,1,OTHER
hemorrhagic strokes,1,CONDITION
vegf,1,DRUG
dual tdcs,1,OTHER
"personalized, tactile cueing system",1,OTHER
step-synchronized tactile cueing,1,OTHER
"personalized, step-synchronized tactile cueing",1,OTHER
tactile cueing at fixed intervals,1,CONTROL
tactile cueing,1,OTHER
cueing,1,OTHER
infraorbital and infratrochlear nerve block,1,OTHER
bilateral infraorbital and infratrochlear nerve block,1,OTHER
mobility problems,1,CONDITION
task-oriented trainings,1,PHYSICAL
combined exercise training,1,PHYSICAL
wireless telemonitoring,1,OTHER
self-management approach,1,BEHAVIOURAL
wireless technologies,1,OTHER
migraine-like attack,1,CONDITION
migraine-like attacks,1,CONDITION
alcohol use,1,CONDITION
tuberous sclerosis complex,1,CONDITION
standard antiepileptic treatment,1,OTHER
laryngeal dystonia,1,CONDITION
voice tremor,1,CONDITION
neurological voice disorders,1,CONDITION
voice dysfunction,1,CONDITION
hbwp,1,PHYSICAL
hbwp without ras,1,CONTROL
ras without walking exercise,1,CONTROL
mental imagery of walking,1,BEHAVIOURAL
"intermittent, stereotypic episodes of frequent seizure activity",1,CONDITION
seizure clusters,1,CONDITION
mechanical insufflation-exsufflation,1,OTHER
lung dysfunction,1,CONDITION
impaired cough response,1,CONDITION
mechanical insufflation exsufflation,1,OTHER
mie,1,OTHER
impaired cough function,1,CONDITION
symptomatic thromboembolism,1,CONDITION
thromboembolic disease,1,CONDITION
tranexamic acid,1,DRUG
total joint arthroplasty,1,CONDITION
plantar vibration,1,OTHER
vibration of the plantar surface of the foot,1,OTHER
oral appliance therapy,1,OTHER
sleep behaviour intervention,1,BEHAVIOURAL
no treatment,1,CONTROL
no sleep training,1,CONTROL
ultrasound-guided suprascapular nerve block,1,OTHER
poststroke,1,CONDITION
palmitoylethanolamide,1,DRUG
dronebinol,1,DRUG
pain exposure physical therapy,1,PHYSICAL
conservative therapy,1,CONTROL
intensive function-oriented physical therapy,1,PHYSICAL
pain exposure in physical therapy,1,PHYSICAL
macedonian therapy,1,PHYSICAL
usual therapy,1,CONTROL
platinum and hydrogel-coated coils,1,OTHER
platinum coil,1,CONTROL
post-traumatic narcolepsy,1,CONDITION
post-traumatic hypersomnia,1,CONDITION
traumatic narcolepsy,1,CONDITION
post traumatic hypersomnia,1,CONDITION
"support interventions by short messages, telephone calls and ambulatory visits",1,BEHAVIOURAL
vascular dementia,1,CONDITION
marrow-sea deficiency,1,CONDITION
antiretroviral therapy naive,1,CONDITION
human immunodeficiency virus type-1,1,CONDITION
abacavir,1,DRUG
dolutegravir,1,DRUG
lamivudine,1,DRUG
hla-b*5701 positive,1,CONDITION
dtg,1,DRUG
dual nucleoside reverse transcriptase inhibitor,1,DRUG
nrti,1,DRUG
hiv 1,1,CONDITION
"pedaling on a tricycle, induced by electrical stimulation of the paralysed muscles",1,PHYSICAL
home-based training for cycling with functional electrical stimulation,1,PHYSICAL
fes-assisted cycling,1,PHYSICAL
fes-cycling,1,PHYSICAL
at-home transcranial direct current stimulation,1,OTHER
tdcs at home,1,OTHER
cimt using prolonged restraint,1,OTHER
cimt using brief manual restraint,1,OTHER
kl16-012,1,DRUG
fibromyalgia refractary to conventional treatment,1,CONDITION
extract of cannabis sativa,1,OTHER
cannabidiol,1,DRUG
akinesia,1,CONDITION
amantadine sulphate,1,DRUG
unimodal (eeg) and bimodal (eeg-fmri) neurofeedback,1,OTHER
after stroke,1,CONDITION
absence of treatment,1,CONTROL
keppra,1,DRUG
tics,1,CONDITION
folic acid,1,DRUG
mild vitamin b12 deficiency,1,CONDITION
dendritic cells loaded with brain tumor stem cells,1,SURGICAL
recurrent or progressive malignant gliomas,1,CONDITION
autologous dendritic cells (dcs) loaded with allogeneic brain tumor stem cells,1,SURGICAL
recurrent brain tumors,1,CONDITION
dcs for immunotherapy,1,SURGICAL
antipsychotics,1,DRUG
arts,1,OTHER
health education,1,CONTROL
arts-based health education,1,OTHER
congestive heart failure,1,CONDITION
chronic obstructive pulmonary disorder,1,CONDITION
asthma,1,CONDITION
weight,1,CONDITION
cardiac,1,CONDITION
human umbilical cord tissue-derived mesenchymal stem cells,1,SURGICAL
allogeneic human umbilical cord tissue-derived stem cells,1,SURGICAL
valproic acid,1,DRUG
oxcarbazepine,1,DRUG
beta interferons,1,DRUG
ifnβ,1,DRUG
dimethyl fumarate,1,DRUG
interferon b,1,DRUG
ifnß,1,DRUG
early- to moderate stage multiple system atrophy,1,CONDITION
allogeneic cell therapy product,1,SURGICAL
homsc300,1,SURGICAL
allogeneic human oral mucosa stem cells,1,SURGICAL
homscs,1,SURGICAL
early to moderate stage multiple system atrophy,1,CONDITION
nicotinic acid,1,DRUG
proactive and reactive perturbation training,1,OTHER
mechanical perturbations during walking,1,OTHER
fall,1,CONDITION
intralipid emulsion,1,CONTROL
head-point acupuncture,1,PHYSICAL
conventional body acupuncture,1,CONTROL
head-acupoints acupuncture,1,PHYSICAL
body-acupoints acupuncture,1,CONTROL
epo,1,DRUG
multi-modality approach,1,OTHER
attention-deficit,1,CONDITION
comorbid attention-deficit,1,CONDITION
combined type attention deficit,1,CONDITION
postural symptoms,1,CONDITION
deficits in attention,1,CONDITION
"high-resolution, relational, resonance-based, electroencephalic mirroring",1,OTHER
moderate to severe insomnia,1,CONDITION
sleep trouble,1,CONDITION
"subthreshold (mild), moderate, or severe clinical insomnia",1,CONDITION
conjugate meningococcal c (mncc) vaccine,1,DRUG
primary dtp/hib vaccination,1,DRUG
group c meningococcal conjugate vaccine,1,DRUG
mmr,1,DRUG
plain polysaccharide vaccine,1,DRUG
phaenylalanine-free protein substitute,1,OTHER
service-enhancement model of ear health facilitators,1,BEHAVIOURAL
hfli,1,BEHAVIOURAL
community-based service-enhancement model of ear and hearing health,1,BEHAVIOURAL
ear and hearing clinical and education support officers,1,BEHAVIOURAL
ear and hearing problems,1,CONDITION
human placental-derived stem-cells,1,SURGICAL
unrelated and related cord blood,1,SURGICAL
malignant hematologic diseases,1,CONDITION
non-malignant disorders,1,CONDITION
human placental-derived stem cells,1,SURGICAL
umbilical cord blood (ucb) stem cells,1,SURGICAL
nonmalignant disorders,1,CONDITION
chemo- and immunotherapy,1,DRUG
ucb,1,SURGICAL
gamma knife thalamotomy,1,RADIOTHERAPY
gamma knife radiosurgery,1,RADIOTHERAPY
gamma knife,1,RADIOTHERAPY
tremors,1,CONDITION
moderate to severe alzheimer's disease,1,CONDITION
standard environmental design,1,OTHER
personalized environmental design,1,OTHER
commercially available vr game,1,OTHER
activities in their everyday,1,CONTROL
chronic post concussion,1,CONDITION
mild head injury,1,CONDITION
post concussion,1,CONDITION
upper-airway and breathing control therapies,1,OTHER
supplemental oxygen,1,OTHER
oxygen,1,OTHER
in-home supportive technology,1,OTHER
in-home assistive technology,1,OTHER
loneliness,1,CONDITION
posttraumatic epilepsy,1,CONDITION
neurology-based collaborative care,1,OTHER
post-traumatic epilepsy,1,CONDITION
response inhibition training,1,BEHAVIOURAL
obsessive-compulsive and related disorders,1,CONDITION
obsessive-compulsive disorder,1,CONDITION
cognitive deficiency,1,CONDITION
computerized cognitive training program,1,BEHAVIOURAL
systematic practice of response inhibition,1,BEHAVIOURAL
40-level computer game,1,BEHAVIOURAL
computerized response inhibition training,1,BEHAVIOURAL
placebo computer training,1,CONTROL
octreotide,1,DRUG
brain substructure-informed radiation planning,1,OTHER
newly diagnosed brain or head and neck tumors,1,CONDITION
brain tumors,1,CONDITION
radiation plan,1,OTHER
standard radiation treatment,1,CONTROL
high-frequency transcranial magnetic stimulation,1,OTHER
taking antipsychotic medication once every two weeks by injection,1,OTHER
taking daily oral medication,1,OTHER
zoloft,1,DRUG
autistic,1,CONDITION
probable alzheimer's disease or progressive supranuclear palsy,1,CONDITION
progressive supranuclear palsy,1,CONDITION
robotic walking,1,PHYSICAL
mobility impairments,1,CONDITION
robotic trainers,1,PHYSICAL
robotic gait trainers,1,PHYSICAL
trexo robotic gait trainers,1,PHYSICAL
schizophrenia spectrum,1,CONDITION
autism spectrum,1,CONDITION
personality disorders,1,CONDITION
scz,1,CONDITION
sad,1,CONDITION
bipolar disorder,1,CONDITION
bd,1,CONDITION
schizotypal personality disorder,1,CONDITION
spd,1,CONDITION
borderline personality disorder,1,CONDITION
bpd,1,CONDITION
"reliable, high-quality video",1,OTHER
high quality pre-surgical videos,1,OTHER
not watch videos,1,CONTROL
videos on their own,1,CONTROL
individualized homeopathic remedies with high grade of pathological similarity,1,OTHER
conventional standardized pharmacological treatment,1,CONTROL
homeopathy,1,OTHER
individualized homeopathic remedies,1,OTHER
conventional pharmacological treatment,1,CONTROL
jns024er,1,DRUG
diabetic neuropathic pain,1,CONDITION
tapentadol,1,DRUG
moderate to severe chronic (lasting a long time) pain,1,CONDITION
painful diabetic peripheral neuropathy,1,CONDITION
median nerve hydro-dissection,1,OTHER
hydro-dissection,1,OTHER
moderate to severe spasticity,1,CONDITION
muscle spasms,1,CONDITION
moderate to severe lower-limb spasticity,1,CONDITION
non-invasive neuromodulation,1,OTHER
"bladder, bowel, and sexual dysfunction",1,CONDITION
electrical stimulation to the spinal cord,1,OTHER
tcscs,1,OTHER
electrodes applied over the skin to deliver electrical stimulation,1,OTHER
stimulation of the spinal cord,1,OTHER
enriched gardens,1,OTHER
enriched garden,1,OTHER
sensory conventional garden,1,CONTROL
nmda-receptor blockade,1,DRUG
intense physiotherapies,1,PHYSICAL
physical and occupational therapies,1,PHYSICAL
active repetitive motor skill-directed rehabilitation,1,PHYSICAL
intense active physiotherapy,1,PHYSICAL
physical and occupational therapy,1,PHYSICAL
standard of care,1,CONTROL
tumour,1,CONDITION
acceptance and commitment therapy,1,BEHAVIOURAL
emergence delrium,1,CONDITION
obesity,1,CONDITION
chronic high tetraplegia,1,CONDITION
functional electrical stimulation,1,OTHER
standardized physical therapy,1,PHYSICAL
conventional therapy,1,PHYSICAL
conventional therapy alone,1,CONTROL
increased intensity of uk conventional therapy,1,CONTROL
multimodal physical therapy treatment,1,OTHER
temporomandibular joint disorder,1,CONDITION
tmd,1,CONDITION
physiotherapy treatment for the temporomandibular joint,1,OTHER
multimodal physiotherapy treatment,1,OTHER
ehapa-ms online intervention,1,OTHER
wearable robotic exoskeleton,1,PHYSICAL
robotic exoskeleton device,1,PHYSICAL
ekso-gt,1,PHYSICAL
walking disability,1,CONDITION
traditional,1,CONTROL
chiropractic,1,OTHER
rheumatologic disease,1,CONDITION
fibromyalgic,1,CONDITION
non-invasive transcranial direct current stimulation,1,OTHER
decline in cognitive functions,1,CONDITION
decline in cognitive function,1,CONDITION
non-invasive brain stimulation techniques,1,OTHER
structured patient education,1,BEHAVIOURAL
program of patient education,1,BEHAVIOURAL
physical training,1,PHYSICAL
tens,1,CONTROL
multidisciplinary delirium prevention strategy,1,OTHER
psychiatry,1,OTHER
addition of psychiatrists to daily icu rounds,1,OTHER
psychiatric evaluation,1,OTHER
psychiatric consultation,1,OTHER
multidisciplinary rounding approach including psychiatry within the icu team,1,OTHER
multidisciplinary approach,1,OTHER
functional decline,1,CONDITION
functional impairments,1,CONDITION
moderate to severe parkinson's disease,1,CONDITION
os-tns,1,OTHER
cardiac disease,1,CONDITION
heart disease,1,CONDITION
postdural puncture headache,1,CONDITION
lower abdominal and lower limb surgeries,1,CONDITION
dexamethazzoe,1,DRUG
abt-126,1,DRUG
cds,1,CONDITION
smokers,1,CONDITION
mild and moderate cts,1,CONDITION
mild and moderate carpal tunnel syndrome,1,CONDITION
umbilical cord derived mesenchymal stem cells transplantation,1,SURGICAL
mesenchymal stem cell transplantation,1,SURGICAL
mesenchymal stem cells derived from umbilical cord,1,SURGICAL
stem cell therapy,1,SURGICAL
ultrasound-guided percutaneous electrical nerve stimulation,1,OTHER
endoscopic surgery,1,CONTROL
ad dementia,1,CONDITION
traditional dysphagia therapy,1,OTHER
mirapex,1,DRUG
individualized rtms,1,OTHER
sra-444,1,DRUG
acute post-craniotomy pain,1,CONDITION
acute postoperative pain,1,CONDITION
outpatient physiotherapy,1,PHYSICAL
outpatient motor skills-based physiotherapy intervention,1,PHYSICAL
sham anodal tdcs,1,CONTROL
physiotherapy session,1,OTHER
physiotherapy treatment protocol,1,OTHER
oral appliance therapies,1,OTHER
virtual reality therapy,1,OTHER
exergaming,1,PHYSICAL
exe,1,PHYSICAL
bal,1,PHYSICAL
cycling,1,PHYSICAL
cyc,1,PHYSICAL
pnf,1,PHYSICAL
standard care wait-listed,1,CONTROL
upper extremity (ue) motor training,1,PHYSICAL
not receive the therapy,1,CONTROL
saos,1,CONDITION
auto cpap,1,OTHER
autocpap,1,OTHER
heart valve replacement,1,CONDITION
ß-secretase inhibitor,1,DRUG
severe renal disease,1,CONDITION
moderate and mild renal impairment,1,CONDITION
nasal septum correction,1,CONDITION
endoscopic sinus surgery,1,CONDITION
nasal bone fracture reduction,1,CONDITION
ultra-early ttm,1,OTHER
covert stroke,1,CONDITION
covert stroke vascular disease,1,CONDITION
aerobic exercise program,1,PHYSICAL
control stretching program,1,CONTROL
"extra ""booster"" exercise sessions",1,PHYSICAL
chinese medicine powder,1,OTHER
auditory and tactile stimulus,1,OTHER
auditory and tactile stimuli,1,OTHER
carbon-14 bia 28-6156,1,DRUG
hearing protection video,1,OTHER
formal training,1,OTHER
training video,1,OTHER
ear plugs,1,OTHER
hand surgeries,1,CONDITION
bupivicaine,1,DRUG
regional pain syndromes,1,CONDITION
refractory and relapsed neuroblastoma,1,CONDITION
solid tumours,1,CONDITION
hycamtin,1,DRUG
relapsed and refractory neuroblastoma,1,CONDITION
solid tumors,1,CONDITION
cohesive thin liquids,1,OTHER
ctl,1,OTHER
mild oropharyngeal dysphagia,1,CONDITION
ischemic/hemorrhagic cerebral cause,1,CONDITION
excitatory theta-burst transcranial magnetic stimulation,1,OTHER
internet intervention,1,OTHER
interactive internet intervention,1,OTHER
static educational website,1,CONTROL
nonsense mutation dystrophinopathy,1,CONDITION
nonsense (premature stop codon) mutation,1,CONDITION
nonsense mutation,1,CONDITION
diazoxide choline,1,DRUG
dccr,1,DRUG
mind-body approaches,1,OTHER
mindfulness sensory awareness exercises,1,OTHER
mindful body awareness check-ins,1,OTHER
sleep problems,1,CONDITION
alglucosidase alfa,1,DRUG
acute seizures,1,CONDITION
status epilepticus,1,CONDITION
prolonged convulsive se,1,CONDITION
vibrational therapy,1,OTHER
vibration,1,OTHER
vibration therapy,1,OTHER
bioresorbable polycaprolactone implant,1,OTHER
orbital injuries,1,CONDITION
titanium mesh,1,CONTROL
bioresorbable implant made of polycaprolactone,1,OTHER
exergames,1,PHYSICAL
exergame,1,PHYSICAL
pantothenate kinase-associated neurodegeneration,1,CONDITION
freezing while walking,1,CONDITION
upper thoracic spinal cord stimulation,1,OTHER
alexander disease,1,CONDITION
axd.,1,CONDITION
lamictal,1,DRUG
intraoperative variations in positive-end expiratory pressure,1,OTHER
supratentorial tumor surgery,1,CONDITION
intraoperative peep,1,OTHER
supratentorial tumor surgeries,1,CONDITION
education,1,BEHAVIOURAL
kernicterus,1,CONDITION
"public, health provider, and maternal education",1,BEHAVIOURAL
jaundice,1,CONDITION
antenatal or postpartum instruction,1,BEHAVIOURAL
not received instruction,1,CONTROL
gamma frequency stimulation,1,OTHER
daily exposure to light and sound stimulation,1,OTHER
severe mental disorder,1,CONDITION
acute traumatic spinal cord injury,1,CONDITION
electric stimulation of the leg's tibial nerve,1,OTHER
acute spinal cord injury,1,CONDITION
ttns,1,OTHER
sarcoid,1,CONDITION
sleep disorders,1,CONDITION
sarcoidotic,1,CONDITION
aquatic exercise,1,PHYSICAL
chronic lbp,1,CONDITION
kinesiophobia,1,CONDITION
catastrophizing,1,CONDITION
"digital application ""play the pain""",1,OTHER
"recurrent, refractory or progressive juvenile pilocytic astrocytomas",1,CONDITION
optic pathway gliomas,1,CONDITION
medial rectus muscle advancement,1,OTHER
resection or medial rectus muscle advancement,1,OTHER
lateral rectus recession,1,OTHER
sbps,1,CONDITION
cannabinoid,1,DRUG
bun/cr-based hydration therapy,1,OTHER
dehydrated,1,CONDITION
hydration therapy on the basis of their presenting bun/cr ratio,1,OTHER
stroke-in-evolution(sie,1,CONDITION
service and hearing dogs,1,OTHER
impairments,1,CONDITION
service dog,1,OTHER
antipsychotic induced psychotic syndrome,1,CONDITION
hyperactivity,1,CONDITION
adherence therapy,1,BEHAVIOURAL
antihypertensive drug treatment,1,DRUG
hypo,1,OTHER
anosmia,1,CONDITION
olfactory dysfunction,1,CONDITION
post-viral od,1,CONDITION
morning light treatment,1,OTHER
physical therapy best practice,1,OTHER
best practices into current stroke rehabilitation physical therapy,1,OTHER
activity monitor,1,OTHER
myhand,1,OTHER
active hand orthosis,1,OTHER
device training program,1,OTHER
arbekacin sulfate,1,DRUG
robotic trunk-support-trainer,1,PHYSICAL
motor learning-based postural and reaching control intervention,1,PHYSICAL
trunk-support-trainer,1,PHYSICAL
motor learning-based intervention,1,PHYSICAL
static trunk support equipment,1,PHYSICAL
context-aware mobile intervention,1,BEHAVIOURAL
technology-supported blended intervention,1,BEHAVIOURAL
mobile social interaction therapy by exposure,1,BEHAVIOURAL
msite,1,BEHAVIOURAL
sleep-wake disturbances,1,CONDITION
dtpa-hbv-ipv vaccine,1,DRUG
hib vaccine,1,DRUG
infanrix hexa,1,DRUG
infanrix penta,1,DRUG
hiberix,1,DRUG
language therapy,1,OTHER
"speech-language treatment,",1,OTHER
nonfluent aphasia,1,CONDITION
ce-certified phonak hearing aids,1,OTHER
hearing aid,1,OTHER
tumorglow,1,OTHER
icg,1,OTHER
autistic disorder,1,CONDITION
standard anesthetic management,1,OTHER
standard general anesthesia care,1,OTHER
standard anesthetic care alone,1,CONTROL
nitrous oxide,1,DRUG
ketorolac,1,DRUG
early huntington disease,1,CONDITION
irritability,1,CONDITION
loss of interest,1,CONDITION
depressed,1,CONDITION
obsessions,1,CONDITION
compulsions,1,CONDITION
resistance exercise training,1,PHYSICAL
frail,1,CONDITION
vitamin d3,1,DRUG
exercise training alone,1,CONTROL
kinesthetic ability trainer-kat2000,1,PHYSICAL
kinesthetic ability trainer 2000,1,PHYSICAL
kat 2000,1,PHYSICAL
balance disorder,1,CONDITION
lumber disc herniation,1,CONDITION
lumber spondylosis,1,CONDITION
gonarthrosis,1,CONDITION
kat 2000 exercises,1,PHYSICAL
kat 2000 balance exercises,1,PHYSICAL
toffee nasal pillows mask,1,OTHER
f&p toffee nasal pillows mask,1,OTHER
prj212,1,DRUG
mild severity alzheimer's disease,1,CONDITION
patient-triggered sensory cues,1,OTHER
"patient triggered sensory(auditory, visual and tactile) cues",1,OTHER
unexpected (randomized) cues,1,OTHER
na-831,1,DRUG
na-83,1,DRUG
high protein diet,1,OTHER
high intake of dietary protein,1,OTHER
robot based gait training,1,PHYSICAL
pulsed shortwave therapy,1,OTHER
migraine attach,1,CONDITION
"chronic, episodic migraines",1,CONDITION
plexiform neurofibroma,1,CONDITION
walking program using physical activity monitors and social networking,1,OTHER
we walk plus intervention,1,OTHER
cervical spinal cord injury,1,CONDITION
magnetically enhanced diffusion,1,OTHER
large vessel occlusion,1,CONDITION
bromocriptine,1,DRUG
neuroleptic-induced hyperprolactinemia,1,CONDITION
precision radiation treatment,1,RADIOTHERAPY
drug-resistant localised epilepsy,1,CONDITION
linac based srt treatment,1,RADIOTHERAPY
vero cell - derived inactivated japanese encephalitis vaccine,1,DRUG
jecevax,1,DRUG
jecevax-,1,DRUG
licensed vaccine,1,CONTROL
jevax,1,DRUG
licenced vaccine,1,CONTROL
warm and cold compress,1,OTHER
relapsing forms of ms,1,CONDITION
injection related erythema,1,CONDITION
superficial hot and cold modalities,1,OTHER
adaptive servo ventilation therapy,1,OTHER
central sleep apnea,1,CONDITION
adaptive servo-ventilation,1,OTHER
adaptive servo ventilation,1,OTHER
heartfailure,1,CONDITION
chronic stable hf,1,CONDITION
teriparatide,1,DRUG
interdisciplinary rehabilitation strategies,1,OTHER
swallowing disorders,1,CONDITION
swallowing complaints,1,CONDITION
vocal and speech disorders,1,CONDITION
focal vibration,1,OTHER
central and peripheral spasticity,1,CONDITION
equistasi,1,OTHER
focal vibrations,1,OTHER
navifus system,1,OTHER
recurrent glioblastoma multiforme,1,CONDITION
fus add-on,1,OTHER
bevacizumab,1,DRUG
radiotherapy,1,RADIOTHERAPY
immune modulation therapy,1,OTHER
ert-naïve or ert-treated pompe disease,1,CONDITION
anti-recombinant human acid α-glucosidase,1,DRUG
anti-rhgaa,1,DRUG
progressive modular rebalancing (rmp) system rehabilitation,1,PHYSICAL
sensory cues for rehabilitation,1,OTHER
rehabilitative program,1,OTHER
parkinson' disease,1,CONDITION
neurocognitive method,1,OTHER
visual sensory cues,1,OTHER
neurophysiological method,1,PHYSICAL
exercise program focused at improving gait,1,PHYSICAL
exercise programs,1,PHYSICAL
apilimod dimesylate,1,DRUG
c9orf72-associated amyotrophic lateral sclerosis,1,CONDITION
c9orf72-associated als,1,CONDITION
c9als,1,CONDITION
brain-injured,1,CONDITION
hyperosmolar therapy,1,OTHER
alteplase,1,DRUG
acute ischemic hemispheric stroke,1,CONDITION
alteplase(rt-pa),1,DRUG
obstructive sleep apnea hypopnea syndrome,1,CONDITION
walking program,1,PHYSICAL
non-active,1,CONTROL
walking,1,PHYSICAL
exercise on a treadmill,1,PHYSICAL
high-performance ecog-based neural interface,1,OTHER
rwj-17021-000,1,DRUG
prim-dj2727,1,DRUG
fecal microbiota transplantation,1,OTHER
mild to moderate alzheimer's disease.,1,CONDITION
paired integrative exercise program,1,PHYSICAL
preventing loss of independence through exercise,1,PHYSICAL
plié,1,PHYSICAL
fbt,1,BEHAVIOURAL
restrictive eating disorders,1,CONDITION
family problem-solving therapy,1,BEHAVIOURAL
family problem solving therapy,1,BEHAVIOURAL
mild to severe adolescent tbi,1,CONDITION
"therapist-guided, face-to-face",1,BEHAVIOURAL
therapist-guided online,1,BEHAVIOURAL
"self-guided, online",1,BEHAVIOURAL
"perceive, recall, plan and perform intervention",1,BEHAVIOURAL
"perceive, recall, plan and perform system",1,BEHAVIOURAL
community-based rehabilitation,1,BEHAVIOURAL
major depressive disorder,1,CONDITION
low muscle mass,1,CONDITION
relative sarcopenia,1,CONDITION
transmuscular quadratus lumborum block,1,OTHER
supra-inguinal fascial iliac compartment block,1,OTHER
total hip arthroplasty,1,CONDITION
iliac fascia block,1,OTHER
hip fractures,1,CONDITION
total hip replacement surgery,1,CONDITION
quadratus lumborum block,1,OTHER
jpfs,1,CONDITION
spontaneous intracerebral hemorrhage,1,CONDITION
active polymyositis,1,CONDITION
active polymyositis (pm)/dermatomyositis (dm),1,CONDITION
ps128,1,OTHER
passive static stretching,1,OTHER
"muscle stretching protocol,",1,OTHER
static passive stretching,1,OTHER
general anesthesia,1,CONDITION
ketamine general anesthesia,1,CONDITION
computer-based training,1,OTHER
methods of interpreting florbetapir (18f) pet scans,1,OTHER
electronic florbetapir (18f) interpretation training program,1,OTHER
rx acculink carotid stent system,1,SURGICAL
major hip surgery,1,CONDITION
major (bony) hip surgery,1,CONDITION
bony hip surgery,1,CONDITION
chronic hip pain,1,CONDITION
placebo (non-active) injections,1,CONTROL
mild peripheral neuropathy,1,CONDITION
impaired functional capacity,1,CONDITION
reduced physical activity,1,CONDITION
intensive and progressive exercise bouts,1,PHYSICAL
training modalities,1,PHYSICAL
intensive,1,PHYSICAL
normal,1,CONTROL
higher training intensities,1,PHYSICAL
intensive training intensities,1,PHYSICAL
vestibular schwannomas,1,CONDITION
gkrs,1,RADIOTHERAPY
newly diagnosed vs,1,CONDITION
vs,1,CONDITION
sham tes,1,CONTROL
emfit mattress sensor,1,OTHER
l-4060slc,1,OTHER
monitor,1,OTHER
dvm-gprs-v2,1,OTHER
generalized tonic-clonic seizures,1,CONDITION
sudden unexpected death in epilepsy,1,CONDITION
mattress alarm system,1,OTHER
emfit monitor,1,OTHER
emfit bed sensor l-4060sl,1,OTHER
generalized convulsions,1,CONDITION
convulsive,1,CONDITION
emfit mattress sensor l-4060slc,1,OTHER
acoustic and new cloud-based notification system,1,OTHER
neuromuscular disease,1,CONDITION
neuromuscular diseases,1,CONDITION
attention-control,1,CONTROL
ac,1,CONTROL
individualized exercise,1,PHYSICAL
supervised exercise,1,PHYSICAL
catastrophic injury,1,CONDITION
one-to-one peer mentoring,1,BEHAVIOURAL
enhanced peer mentor interactions,1,BEHAVIOURAL
traumatic spinal cord injury,1,CONDITION
traditional peer mentor types of interactions,1,CONTROL
enhanced peer mentor program,1,BEHAVIOURAL
one-on-one initiative,1,BEHAVIOURAL
tremor,1,CONDITION
freezing in the subthalamic region,1,CONDITION
prehospital full advanced life support,1,OTHER
telemedicine system,1,OTHER
sas,1,CONDITION
interoperable telemedicine system,1,OTHER
peep,1,OTHER
erector spinae plane (esp) block,1,OTHER
caudal block,1,CONTROL
acute brain-injured,1,CONDITION
elevated intracranial pressure,1,CONDITION
blindness,1,CONDITION
multimodal opiate-sparing analgesia,1,OTHER
traditional opiate based analgesia,1,OTHER
multimodal analgesia,1,OTHER
conventionel opiod analgesia,1,OTHER
nerve transfers,1,SURGICAL
nerve transfer,1,SURGICAL
cervical spinal cord injuries,1,CONDITION
stereotactic operation,1,SURGICAL
basal ganglion hemorrhage,1,CONDITION
stereotactic puncture,1,SURGICAL
aspiration,1,SURGICAL
small hematoma in deep basal ganglia,1,CONDITION
carbon monoxide's headache,1,CONDITION
sham ultrasound therapy,1,CONTROL
ultrasound treatment,1,OTHER
loss of muscle health,1,CONDITION
muscle atrophy,1,CONDITION
muscle loss,1,CONDITION
u-health service using mobile device,1,OTHER
mobile programs,1,OTHER
occupational and speech therapy,1,OTHER
remotely controlled mandibular positioner,1,OTHER
maxillomandibular advancement surgery,1,CONDITION
maxillomandibular advancement (mma) surgery,1,CONDITION
mma surgery,1,CONDITION
remote controlled mandibular positioner,1,OTHER
mma,1,CONDITION
home and in-laboratory testing,1,OTHER
home testing,1,OTHER
in-lab testing,1,OTHER
succinic semialdehyde dehydrogenase deficiency,1,CONDITION
gaba(b) receptor antagonist,1,DRUG
spastic hemiplegic cerebral palsy,1,CONDITION
intermittent theta-burst stimulation transcranial magnetic stimulation,1,OTHER
transcranial magnetic stimulation (tms) targeting the dorsolateral prefrontal cortex (dlpfc) or the primary motor cortex (m1),1,OTHER
m1,1,OTHER
pain catastrophization,1,CONDITION
placebo together with tms,1,CONTROL
ads,1,CONDITION
self-balancing walking system atalante,1,PHYSICAL
robotic locomotor training,1,PHYSICAL
robot-assisted gait therapy,1,PHYSICAL
test catheters,1,OTHER
speedicath catheters,1,OTHER
test catheter,1,OTHER
speedicath (sc) catheter,1,OTHER
bi-axial rotating magnetic field therapy,1,OTHER
refractory neuropathic foot pain,1,CONDITION
pulsed magnetic stimulating,1,OTHER
moderate-severe foot pain,1,CONDITION
induced forced limb loading,1,PHYSICAL
complete or incomplete sci,1,CONDITION
checkpoint inhibitor of pd-1,1,DRUG
first relapse,1,CONDITION
b-cell acute lymphoblastic leukemia,1,CONDITION
relapsed,1,CONDITION
relapsed b-all,1,CONDITION
pre- vs. postoperative scalp block,1,OTHER
selective scalp block,1,OTHER
multiple sclerosis with progressive subtypes,1,CONDITION
progressive multiple sclerosis,1,CONDITION
theta-burst-stimulation,1,OTHER
hemipresis,1,CONDITION
mild-moderate stage amyotrophic lateral sclerosis,1,CONDITION
audiobooks for hearing loss (hl) app,1,OTHER
psychotic,1,CONDITION
spastic diplegic cerebral palsy,1,CONDITION
minor- to moderate-risk noncardiac surgery,1,CONDITION
noncardiac surgeries,1,CONDITION
acw135 polysaccharide vaccine,1,DRUG
"meningitis a, c and w135",1,CONDITION
mencevax acw polysaccharide vaccine,1,DRUG
"men a, c and w135",1,CONDITION
men a,1,CONDITION
gaming mechanics,1,OTHER
telerehabilitation,1,PHYSICAL
motivational strategies,1,BEHAVIOURAL
home tele-rehabilitation program,1,PHYSICAL
tele-rehabilitation- based home exercise program,1,PHYSICAL
home exercise,1,PHYSICAL
simulated rehabilitation activities,1,PHYSICAL
passive exoskeleton,1,PHYSICAL
exercise at home,1,PHYSICAL
motivationally enhanced simulations,1,BEHAVIOURAL
un-enhanced control,1,CONTROL
motivational enhancements,1,BEHAVIOURAL
tele-rehabilitation program,1,PHYSICAL
motivational enhancement,1,BEHAVIOURAL
autonomous rehabilitation programs,1,PHYSICAL
cytomegalovirus,1,CONDITION
asymptomatic congenital cytomegalovirus,1,CONDITION
ccmv,1,CONDITION
hypometria,1,CONDITION
behavioral cognitive rehabilitation,1,BEHAVIOURAL
upper airway obstruction,1,CONDITION
hypotonia,1,CONDITION
hypotonic upper airway obstruction,1,CONDITION
huao,1,CONDITION
web-based situational feedback,1,OTHER
situational feedback,1,OTHER
patient-provider communication,1,OTHER
regular situational feedback,1,OTHER
enhancing self-management,1,OTHER
chronic non-malignant pain,1,CONDITION
"""situational"" feedback",1,OTHER
conventional interventions in a clinical setting,1,CONTROL
quick response feedback using mobile communication technology,1,OTHER
coronavirus disease 2019,1,CONDITION
acute and / or delayed brain damage,1,CONDITION
cranial nerves damage,1,CONDITION
sleep and breathing problems,1,CONDITION
multi-component treatment strategies,1,OTHER
multicomponent intervention programme,1,OTHER
nutritional counselling/dietary intervention,1,OTHER
information and communications technology intervention,1,OTHER
healthy aging lifestyle education programme,1,CONTROL
mobility disability,1,CONDITION
sleep disorder,1,CONDITION
chronic fatigue syndrome,1,CONDITION
chronic fatigue,1,CONDITION
fetoscopic repair,1,SURGICAL
fetal surgery,1,SURGICAL
fetoscopic technique,1,SURGICAL
endoscopic repair,1,SURGICAL
carotid artery stenting,1,SURGICAL
asymptomatic carotid artery narrowing,1,CONDITION
stenting,1,SURGICAL
"manometric- assisted anal relaxation, muscle coordination and simulated defecation training",1,PHYSICAL
sham feedback therapy,1,CONTROL
diet,1,CONTROL
laxatives,1,CONTROL
dyssynergia,1,CONDITION
nf2-related tumors,1,CONDITION
endostatin,1,DRUG
exelon,1,DRUG
biofreeze,1,DRUG
gel with a menthol scent,1,CONTROL
thoracic endovascular aortic repair,1,CONDITION
neurological injury,1,CONDITION
vascular brain infarction,1,CONDITION
neurocognitive impairment,1,CONDITION
individual auditory cueing device,1,OTHER
apple ipod-shuffle,1,OTHER
individualised auditory cueing,1,OTHER
narcoleptic,1,CONDITION
cataplexy,1,CONDITION
persistent post-traumatic headache,1,CONDITION
pth,1,CONDITION
mild traumatic brain injury,1,CONDITION
mtbi,1,CONDITION
radial extracorpeal shock wave therapy,1,OTHER
radial extracorporeal shock wave intervention,1,OTHER
mixed dementia with alzheimer's and vascular components,1,CONDITION
sma,1,CONDITION
early stuttering,1,CONDITION
ais,1,CONDITION
long-term motor training,1,PHYSICAL
bimanual coordination training,1,PHYSICAL
anodal transcranial direct current,1,OTHER
spm 927,1,DRUG
musculoskeletal pain,1,CONDITION
atypical antipsychotics,1,DRUG
atypical antipsychotic,1,DRUG
post covid-19 syndrome,1,CONDITION
vagal stimulation with the t-vns method,1,OTHER
prolonged covid,1,CONDITION
left ear transcutaneous vagus nerve stimulation,1,OTHER
bilateral auricular transcutaneous vagus nerve stimulation,1,OTHER
migraine attacks,1,CONDITION
eating disorder fears,1,CONDITION
virtual relapse prevention program,1,BEHAVIOURAL
fears,1,CONDITION
fed-f treatment,1,BEHAVIOURAL
focused ultrasound delivery of exosomes,1,OTHER
refractory depression,1,CONDITION
neurodegenerative dementias,1,CONDITION
exosome,1,OTHER
transcranial ultrasound,1,OTHER
"refractory, treatment resistant depression",1,CONDITION
neurodegenerative dementia,1,CONDITION
ischemic subtentorial stroke,1,CONDITION
subacute phase of stroke,1,CONDITION
early schizophrenia,1,CONDITION
rns® system responsive stimulation,1,OTHER
rns system,1,OTHER
refractory partial onset epilepsy,1,CONDITION
pediatric high grade gliomas at first recurrence,1,CONDITION
autologous stem cell transplant,1,SURGICAL
peripheral blood stem cell,1,SURGICAL
pbsc,1,SURGICAL
carboplatin,1,DRUG
thiotepa,1,DRUG
etoposide,1,DRUG
glioma,1,CONDITION
muscle relaxation,1,OTHER
phonological alexia,1,CONDITION
1:1 training to improve reading skills,1,OTHER
continuous positive airways pressure,1,OTHER
exergame balance training,1,PHYSICAL
traditional weight shifting training,1,PHYSICAL
balance training programs,1,PHYSICAL
exergame systems,1,PHYSICAL
weight-shifting training,1,PHYSICAL
early launching of nocturnal non invasive ventilation,1,OTHER
early launching of night non invasive ventilation,1,OTHER
early introduction of non invasive ventilation,1,OTHER
myotonic dystrophy,1,CONDITION
caregiver sms reminder,1,OTHER
scalable short message service (sms) system,1,OTHER
sms text messages,1,OTHER
ultrasound-guided erector spinae plane block,1,OTHER
open splenectomy surgery,1,CONDITION
ultrasound-guided paravertebral block,1,OTHER
open splenectomy,1,CONDITION
neuromodulation technique,1,OTHER
electrical stimulation of the cerebellum,1,OTHER
virtual reality protocol,1,OTHER
excitatory stimulation of the cerebellum,1,OTHER
pd-rbd,1,CONDITION
sglt2-inhibitor,1,DRUG
sodium glucose co-transporter 2 (sglt2)-inhibitor,1,DRUG
sglt2-inhibitors,1,DRUG
parkinsonian syndrome,1,CONDITION
refractory idiopathic inflammatory myopathies,1,CONDITION
interleukin-1 (il-1) blocking agent,1,DRUG
treatment-resistant inflammatory myopathies,1,CONDITION
refractory polymyositis,1,CONDITION
pm,1,CONDITION
dm,1,CONDITION
ibm,1,CONDITION
early and mid-stage dementia:,1,CONDITION
early and mid-stage dementia,1,CONDITION
solian solution,1,DRUG
triamcinolone,1,DRUG
mononeuropathy,1,CONDITION
mild to moderate cts,1,CONDITION
neural mobilization techniques,1,PHYSICAL
slider and tensioner techniques,1,PHYSICAL
sporadic inclusion body myositis,1,CONDITION
sibm,1,CONDITION
thalidomide,1,DRUG
five star rated helmets only,1,OTHER
epileptogenic,1,CONDITION
drug resistant partial epilepsies,1,CONDITION
cognitive and gait impairment,1,CONDITION
motor and cognitive dysfunction,1,CONDITION
parkinson disease dementia,1,CONDITION
motor and cognitive impairment,1,CONDITION
deep brain stimulation in the basal ganglia,1,OTHER
deep brain stimulation surgery,1,OTHER
strengthening oropharyngeal muscles,1,PHYSICAL
oropharyngeal exercise,1,PHYSICAL
o-pe,1,PHYSICAL
o-pes,1,PHYSICAL
sham control,1,CONTROL
crps-ii,1,CONDITION
exposure therapy,1,OTHER
cortical interventions,1,OTHER
complex regional pain syndrome ii,1,CONDITION
graded exposure therapy,1,OTHER
methods targeting cortical reorganisation,1,OTHER
branched chain amino acid,1,DRUG
moderate intensity exercises,1,PHYSICAL
cerebrovascular events,1,CONDITION
occlusive carotid artery disorders,1,CONDITION
silent brain ischemia,1,CONDITION
asymptomatic carotid stenosis,1,CONDITION
sb-649868,1,DRUG
noise induced situational insomnia,1,CONDITION
auditory hallucinations,1,CONDITION
acoustic-verbal hallucinations,1,CONDITION
dissociative symptoms,1,CONDITION
chronic tics,1,CONDITION
"treatment resistant depression, schizophrenia, and obsessive compulsive disorder",1,CONDITION
"severe depression,",1,CONDITION
treatment-refractory cases of schizophrenia and obsessive compulsive disorder,1,CONDITION
"severe depression, schizophrenia, and ocd",1,CONDITION
rhythmic auditory cueing,1,OTHER
locomotion training,1,PHYSICAL
spinal cord injured,1,CONDITION
focal activation of intraspinal circuitry,1,OTHER
intraspinal micro-stimulation,1,OTHER
unilateral versus bilateral intensive training,1,PHYSICAL
unimanual intensive training,1,PHYSICAL
bimanual intensive training,1,PHYSICAL
moderate and severe dementia,1,CONDITION
individual pain management,1,OTHER
individual pain treatment,1,OTHER
low-level mechanical vibration,1,OTHER
low-level mechanical vibrations,1,OTHER
25oh vitamin d,1,DRUG
end stage renal disease,1,CONDITION
haemodialysis,1,CONDITION
severe renal impairment,1,CONDITION
hemodialysis,1,CONDITION
human placenta- derived cells,1,SURGICAL
vehicle control,1,CONTROL
psychological treatment,1,BEHAVIOURAL
interactive website,1,BEHAVIOURAL
wait list/delayed start,1,CONTROL
in-person habit reversal training,1,BEHAVIOURAL
web-based self-help,1,BEHAVIOURAL
wait list,1,CONTROL
intracranial hypertension,1,CONDITION
b-blockers,1,DRUG
a2 agonists,1,DRUG
elective craniotomy,1,CONDITION
huntington´s disease gene expansion carriers,1,CONDITION
mnb rlp2086,1,DRUG
meningococcal b rlp2086 vaccine,1,DRUG
moderate to severe migraine,1,CONDITION
nscs,1,SURGICAL
idiopathic pd,1,CONDITION
eliglustat,1,DRUG
motor response complications,1,CONDITION
weakness of the lower limb,1,CONDITION
gait difficulties,1,CONDITION
muscle weakness,1,CONDITION
postopreative agitation,1,CONDITION
modification of threat interpretation bias,1,BEHAVIOURAL
neurodegenerative movement disorders,1,CONDITION
web-based cognitive bias modification intervention,1,BEHAVIOURAL
gynecologic cancer,1,CONDITION
sham acupuncture,1,CONTROL
dietary recommendations,1,CONTROL
normal and high protein diets,1,OTHER
adiposity,1,CONDITION
high and normal protein,1,OTHER
high protein,1,OTHER
normal protein,1,CONTROL
focused ultrasound-induced blood-brain barrier disruption,1,OTHER
orexigenic therapy,1,OTHER
chemosensory abnormalities,1,CONDITION
taste and/or smell (chemosensory) abnormalities,1,CONDITION
interferon γ-1b,1,DRUG
interferon-γ 1b,1,DRUG
low dose irradiation,1,RADIOTHERAPY
low-dose irradiation,1,RADIOTHERAPY
early to moderate hd,1,CONDITION
respiratory disturbances,1,CONDITION
subcostal transversus abdominis plane block,1,OTHER
open liver resection,1,CONDITION
"benign, malignant or metastatic hepatic tumor",1,CONDITION
transversus abdominis plane [tap] block,1,OTHER
somatic pain,1,CONDITION
esbp,1,OTHER
tap,1,OTHER
open liver resection surgery,1,CONDITION
video game-based physical activity training,1,PHYSICAL
videogame-based physical activity training,1,PHYSICAL
nature-based park visit program,1,OTHER
nature connections park visit program,1,OTHER
weekly telephone/internet support meetings,1,OTHER
alzheimer's disease at beginning to moderate stages,1,CONDITION
sporadic alzheimer's disease,1,CONDITION
alzheimer's,1,CONDITION
alzheimer's disease dementia at beginning to moderate stage,1,CONDITION
alternating-frequency dbs,1,OTHER
alternating-frequency deep brain stimulation,1,OTHER
lactobacillus probiotic,1,OTHER
drug resistant epilepsy,1,CONDITION
dysbiosis,1,CONDITION
dre,1,CONDITION
lactobacillus population,1,OTHER
probiotic bacteria,1,OTHER
lactobacillus,1,OTHER
probiotic treatment,1,OTHER
robotic arm exoskeleton,1,OTHER
motor impairment,1,CONDITION
robotic technology,1,OTHER
robotic arm/hand device,1,OTHER
bci robotic-device,1,OTHER
inactive substance pill,1,CONTROL
fmpo,1,OTHER
family member provider,1,OTHER
enhanced treatment as usual approach,1,CONTROL
emotional deficits,1,CONDITION
intervention for improving emotional processing,1,OTHER
restless legs,1,CONDITION
oud,1,CONDITION
opioid use disorder,1,CONDITION
physician prehospital management,1,OTHER
severe blunt head injury,1,CONDITION
advanced interventions as provided by a physician at an accident scene,1,OTHER
severe head injury,1,CONDITION
rapid sequence intubation (rsi) airway management,1,OTHER
blood transfusions,1,OTHER
surgical procedures,1,SURGICAL
early supination,1,OTHER
external rotation repositioning,1,OTHER
birth related brachial plexus injury,1,CONDITION
supination,1,OTHER
external rotation,1,OTHER
birth related brachial plexus injuries,1,CONDITION
iloperidone,1,DRUG
ischemic schizophrenia,1,CONDITION
personal sound amplification products,1,OTHER
psaps,1,OTHER
activities in mse alone,1,OTHER
massage therapy in usual care environment,1,OTHER
usual care with attention,1,CONTROL
usual care only,1,CONTROL
cold-sensitive fibromyalgia syndrome,1,CONDITION
cold-sensitive fibromyalgia,1,CONDITION
pelvic pain,1,CONDITION
pulsed radiofrequency,1,OTHER
pudendal neuralgia,1,CONDITION
pn,1,CONDITION
myasthenia gravis,1,CONDITION
endovascular repair by stenting,1,SURGICAL
severe (70% and higher) asymptomatic carotid stenosis,1,CONDITION
multifactorial and personalized program for fall prevention,1,BEHAVIOURAL
interdisciplinary multi-component and personalized multi-factorial intervention,1,BEHAVIOURAL
mechanically ventilated,1,CONDITION
hydroxymethylbutyrate,1,DRUG
eicosapentaenoic acid,1,DRUG
breathing machines,1,CONDITION
sumatriptan,1,DRUG
hyperammonemia,1,CONDITION
impaired hepatic ureagenesis,1,CONDITION
nutritional intervention,1,OTHER
ensure enlive,1,OTHER
sleep apnea management group,1,BEHAVIOURAL
moderate-to-severe obstructive sleep apnea,1,CONDITION
sleep apnea management (sam) grouped based-intervention,1,BEHAVIOURAL
regular non-sleep prescribing provider,1,CONTROL
posterior fossa lesions,1,CONDITION
ischemia,1,CONDITION
high blood sugars,1,CONDITION
early phase psychosis,1,CONDITION
cognitive remediation program,1,BEHAVIOURAL
early phase schizophrenia spectrum disorders,1,CONDITION
remediation program,1,BEHAVIOURAL
lumbo-sacral mobilization,1,OTHER
loss of axial rotation,1,CONDITION
mobilization techniques,1,OTHER
manipulation,1,OTHER
grade a and grade b mobilization applications,1,OTHER
lumbosacral mobilization,1,OTHER
gsk2202083a vaccine,1,DRUG
gsk2202083 vaccine,1,DRUG
prevenar,1,DRUG
rotarix,1,DRUG
robot-assisted locomotor training,1,PHYSICAL
subacute post-stroke non-ambulatory hemiplegic,1,CONDITION
neurodevelopmental treatment,1,CONTROL
robotic assisted locomotor training,1,PHYSICAL
robotic-assisted gait therapy,1,PHYSICAL
lokomat,1,PHYSICAL
placebo rtms,1,CONTROL
active rtms,1,OTHER
autolitt,1,OTHER
autolitt laser treatment,1,OTHER
recurrent/progressive brain tumors,1,CONDITION
autolitt system,1,OTHER
recurrent/progressive glioblastoma multiforme tumors,1,CONDITION
gbm,1,CONDITION
palate repair,1,CONDITION
cleft palate repair,1,CONDITION
flavonoids-,1,DRUG
dha-,1,DRUG
lgmd,1,CONDITION
mds,1,CONDITION
flavonoids,1,DRUG
omega3s,1,DRUG
muscular pain,1,CONDITION
continuous theta-burst stimulation,1,OTHER
brain safe app,1,OTHER
attention control medication list app,1,OTHER
refractory epilepsy,1,CONDITION
refractory (drug-resistant) epilepsy,1,CONDITION
pocd,1,CONDITION
animal intervention,1,OTHER
presence of the animal,1,OTHER
major neuro cognitive disorder,1,CONDITION
ncd,1,CONDITION
same stimulation without the dog's response,1,CONTROL
workshops,1,OTHER
intervention of the dog,1,OTHER
cognitive stimulation,1,OTHER
animal assisted therapy,1,OTHER
circadian sleep disturbance,1,CONDITION
disrupted sleep cycle,1,CONDITION
primary immunodeficiency,1,CONDITION
unexplained recurrent and/or severe infections with encapsulated bacteria,1,CONDITION
antibody deficiencies,1,CONDITION
complement deficiencies,1,CONDITION
primary immunodeficiencies,1,CONDITION
recurrent and/or severe bacterial infections,1,CONDITION
upper and lower respiratory tract infections,1,CONDITION
bacterial infections,1,CONDITION
recurrent infections,1,CONDITION
severe bacterial infection,1,CONDITION
tablet-based app,1,OTHER
"symmetric, sensorineural hearing loss",1,CONDITION
self-regulation learning,1,BEHAVIOURAL
mcimt,1,PHYSICAL
self-regulation,1,BEHAVIOURAL
sr,1,BEHAVIOURAL
immersive digital reality-augmenting system,1,OTHER
critical illness,1,CONDITION
systems of active monitoring,1,OTHER
incentive program for physical activity,1,OTHER
early and advanced parkinson's disease,1,CONDITION
sound stimulation,1,OTHER
chronic pure tone tinnitus,1,CONDITION
auditory stimulation,1,OTHER
combined stimulation,1,OTHER
polyethylene glycol 3350-electrolyte solution,1,DRUG
miralax,1,DRUG
psychoeducation,1,BEHAVIOURAL
anti-mag igm monoclonal gammopathy,1,CONDITION
anti-mag monoclonal igm gammopathy,1,CONDITION
anti-cd 20 monoclonal antibody,1,DRUG
anti-mag polyneuropathy,1,CONDITION
quadrivalent meningococcal conjugate vaccine,1,DRUG
"meningococcal polysaccharide (serogroups a, c, y and w) tetanus toxoid (menacyw) conjugate vaccine",1,DRUG
telerehabilitation virtual reality,1,OTHER
"telerehabilitation program specifically designed for upper limbs, based on virtual reality",1,OTHER
3d printed mandibular advancement device,1,OTHER
oa,1,OTHER
oa device,1,OTHER
cognitive rehab,1,OTHER
memory deficits,1,CONDITION
traumatic brain injuries,1,CONDITION
startle rehabilitation therapy,1,OTHER
apraxia,1,CONDITION
severe-to-moderate stroke,1,CONDITION
using different sounds to improve therapy,1,OTHER
"sounds"" are softer",1,CONTROL
"high-frequency, word-picture verification/ auditory-repetition treatment",1,OTHER
without,1,CONTROL
task-specific training on the c-mill,1,PHYSICAL
waiting list,1,CONTROL
telestroke patient consultation,1,OTHER
other national and international telestroke programs,1,CONTROL
lumbosacral radicular pain,1,CONDITION
integrated solution for sustainable care,1,OTHER
integrated care platform,1,OTHER
multimorbidity,1,CONDITION
diminished intrinsic capacity,1,CONDITION
integrated patient-centred approach-,1,OTHER
postural orthostatic tachycardia syndrome,1,CONDITION
compression garment,1,OTHER
commercially available waist-high and abdominal compression garments,1,OTHER
translabyrinthine vestibular schwannoma resection,1,CONDITION
cochlear implantation,1,CONDITION
translabyrinthine surgery for vestibular schwannoma resection,1,CONDITION
cochlear implant,1,CONDITION
asymmetric sensorineural hearing loss,1,CONDITION
closed-loop neuromodulation device,1,OTHER
standard practices of dbs programming,1,CONTROL
cerebello-spinal tdcs,1,OTHER
neurodegenerative ataxia,1,CONDITION
neurodegenerative cerebellar ataxias,1,CONDITION
cerebellar ataxias,1,CONDITION
cerebellar anodal tdcs,1,OTHER
spinal cathodal tdcs,1,OTHER
neurodegenerative cerebellar ataxia,1,CONDITION
stage 3 idiopathic parkinson's disease,1,CONDITION
alternating current brain stimulation,1,OTHER
transcranial alternating current brain stimulation,1,OTHER
gamma tacs on the posterior parietal cortex,1,OTHER
phn,1,CONDITION
l-arginine,1,DRUG
melas syndrome,1,CONDITION
melas,1,CONDITION
'stroke-like' episodes,1,CONDITION
neck pain,1,CONDITION
trigger points of the levator scapula muscle,1,CONDITION
mechanical cervicalgia,1,CONDITION
myofascial pain syndrome,1,CONDITION
trigger points in levator scapulae muscle,1,CONDITION
intramuscular stimulation,1,OTHER
remote ischemic conditioning(ric,1,OTHER
symptomatic vertebrobasilar lesion of atherosclerosis,1,CONDITION
autologous mononuclear cell therapy,1,SURGICAL
alcohol use disorder,1,CONDITION
social withdrawal,1,CONDITION
sham ctdcs,1,CONTROL
bbs,1,PHYSICAL
phobias,1,CONDITION
fear of heights,1,CONDITION
phobia,1,CONDITION
waitlist,1,CONTROL
darbetin,1,DRUG
nerotin,1,DRUG
persistent vegetative state,1,CONDITION
minimally conscious state,1,CONDITION
tauopathy,1,CONDITION
synucleinopathy,1,CONDITION
remote ischemic preconditioning,1,OTHER
cervical decompression surgery,1,CONDITION
ripc,1,OTHER
cervical decompression surge,1,CONDITION
bio-electro stimulation therapy,1,OTHER
bio electro stimulation therapy,1,OTHER
b.e.s.t.,1,OTHER
post covid-19 parosmia,1,CONDITION
post covid 19 parosmia,1,CONDITION
(r)-2-amino-3 phenylpropylcarbamate hydrochloride,1,DRUG
excessive sleepiness,1,CONDITION
jzp-110,1,DRUG
adeno-tonsilectomy,1,CONDITION
adeno-tonsillectomy,1,CONDITION
handwriting interventions,1,OTHER
micrographia,1,CONDITION
handwriting practice stimulus,1,OTHER
micrograpthia,1,CONDITION
diverging line cued handwriting intervention,1,OTHER
parallel line cued handwriting intervention,1,CONTROL
handwriting intervention,1,OTHER
vy-aadc01,1,OTHER
fluctuating responses to levodopa,1,CONDITION
aadc gene transfer,1,OTHER
transformation of dormant spinal networks,1,OTHER
neurogenic bladder,1,CONDITION
scone neuromodulation therapy,1,OTHER
inactive sham,1,CONTROL
neurogenic lower urinary tract dysfunction,1,CONDITION
bladder pain,1,CONDITION
chronic pelvic pain,1,CONDITION
oral contraceptives,1,DRUG
oc,1,DRUG
cyclical ocs,1,DRUG
cos,1,CONDITION
protective device,1,OTHER
concussions,1,CONDITION
without mouthguard and tight jaws,1,CONTROL
mouthguard,1,OTHER
tight jaws,1,OTHER
igf-i,1,DRUG
igf-i.,1,DRUG
resistant to dopaminergic therapy,1,CONDITION
motor neurone disease,1,CONDITION
daytime sleepiness,1,CONDITION
drowsiness,1,CONDITION
mild mood complaints,1,CONDITION
fitbit versa 3,1,OTHER
post-operative cerebrospinal fluid (csf) leaks,1,CONDITION
online fundamental motor skills,1,PHYSICAL
autism,1,CONDITION
wait-listed home-based,1,CONTROL
physical education-related activity items,1,PHYSICAL
wait-list,1,CONTROL
chronic benign headache,1,CONDITION
tension headaches,1,CONDITION
relaxation training,1,OTHER
headache pain,1,CONDITION
anger,1,CONDITION
progressive muscle relaxation training,1,OTHER
thermal biofeedback,1,OTHER
tension headache,1,CONDITION
muscle tension,1,CONDITION
tcm intervention,1,OTHER
distal symmetric peripheral neuropathy,1,CONDITION
tcm,1,OTHER
aids,1,CONDITION
placebo-,1,CONTROL
behavioral techniques,1,BEHAVIOURAL
robotic gait-devices,1,OTHER
robotic devices,1,OTHER
gait rehabilitation,1,OTHER
internet-based self-help training,1,BEHAVIOURAL
internet-based guided self-help training,1,BEHAVIOURAL
discussion forum group,1,CONTROL
support program for home care staff,1,BEHAVIOURAL
peer support program,1,BEHAVIOURAL
released unitron ric (receiver in canal) and bte (behind the ear) hearing aid models,1,OTHER
unitron released hearing aids,1,OTHER
ric,1,OTHER
bte,1,OTHER
inefficient cough,1,CONDITION
acute respiratory failure,1,CONDITION
mechanical exsufflation,1,OTHER
manual techniques of physiotherapy,1,OTHER
instrumental and manual of cough assistance,1,OTHER
down's syndrome,1,CONDITION
ds,1,CONDITION
sedation regimens,1,OTHER
post-sedation delirium,1,CONDITION
different drug regimens,1,OTHER
repetitive subconcussive head impacts,1,CONDITION
leukoaraiosis,1,CONDITION
blood pressure reduction,1,OTHER
white matter lesions,1,CONDITION
lowering blood pressure,1,OTHER
ranirestat(as-3201,1,DRUG
aldose reductase inhibitor,1,DRUG
diabetic,1,CONDITION
sensorimotor polyneuropathy,1,CONDITION
brl-049653,1,DRUG
stelo exoskeleton,1,OTHER
gait impairment,1,CONDITION
stelo,1,OTHER
exoskeleton based on modular technology,1,OTHER
stelo modular exoskeleton,1,OTHER
motor and cognitive deficits,1,CONDITION
late-stage parkinson,1,CONDITION
periodontal treatment,1,OTHER
intensive periodontal treatment,1,OTHER
periodontal stroke,1,CONDITION
periodontal intervention,1,OTHER
aggressive periodontal therapy,1,OTHER
advanced cognitive stimulation therapy,1,BEHAVIOURAL
acst,1,BEHAVIOURAL
cognitive stimulation therapy,1,BEHAVIOURAL
cst,1,BEHAVIOURAL
pku synergy,1,OTHER
routine nutritional management,1,OTHER
usual dietary and/or protein substitute regimen,1,CONTROL
periventricular leukomalacia,1,CONDITION
preterm birth,1,CONDITION
treatment of orthostatic hypotension,1,OTHER
cerebral blood flow biofeedback training,1,OTHER
cognitive and behavioral deficits,1,CONDITION
dementing,1,CONDITION
ftd,1,CONDITION
biofeedback training,1,OTHER
rhythmic stimulation,1,OTHER
22q11.ds,1,CONDITION
traumatic encephalopathy syndrome,1,CONDITION
chronic traumatic encephalopathy,1,CONDITION
brain-computer interfaces,1,OTHER
assistive devices,1,OTHER
brain-computer interface,1,OTHER
mi-based bcis,1,OTHER
bcis,1,OTHER
closed-loop bci,1,OTHER
increased arterial stiffness of elastic arteries,1,CONDITION
increased arterial stiffness,1,CONDITION
systemic arterial stiffness,1,CONDITION
continuous vibration,1,PHYSICAL
leg and systemic pwv,1,PHYSICAL
leg pwv,1,PHYSICAL
silent atrial fibrillation,1,CONDITION
first-ever atherothrombotic or lacunar stroke,1,CONDITION
afl,1,CONDITION
contract-relax technique of proprioceptive neuromuscular facilitation,1,PHYSICAL
static stretching exercise,1,PHYSICAL
odm-104,1,DRUG
affitope® pd01a.,1,DRUG
untreated control,1,CONTROL
marijuana,1,OTHER
transcutaneous stimulation,1,OTHER
mobility device use,1,OTHER
non-invasive spinal stimulation,1,OTHER
mobility devices,1,OTHER
cognitive impairment,1,CONDITION
traditional swallowing therapy,1,OTHER
neuromuscular electrostimulation,1,OTHER
sham- nmes,1,CONTROL
mild dysphagia,1,CONDITION
severe dysphagia,1,CONDITION
no swallow exercises,1,OTHER
swallowing exercises,1,OTHER
standard speech therapy,1,OTHER
active nmes,1,OTHER
speech therapy,1,CONTROL
sham nmes,1,CONTROL
dysphagic,1,CONDITION
cognitive task,1,OTHER
submaximal isometric exercise,1,PHYSICAL
physical and cognitive tasks,1,OTHER
mental math,1,OTHER
ecp,1,OTHER
secondary progressive multiple sclerosis,1,CONDITION
spms,1,CONDITION
-ecp,1,OTHER
mind at home-streamlined dementia care coordination intervention,1,BEHAVIOURAL
care coordination,1,BEHAVIOURAL
identification of needs and individualized care planning,1,OTHER
dementia education and skill building,1,OTHER
"coordination, referral and linkage of services",1,OTHER
initial in-home needs assessment,1,CONTROL
remifentanil,1,DRUG
hyperalgesia,1,CONDITION
thyroidectomy,1,CONDITION
residual daytime sleepiness,1,CONDITION
exposure to bright light,1,OTHER
reduced dose craniospinal radiotherapy,1,RADIOTHERAPY
newly-diagnosed standard-risk posterior fossa primitive neuro-ectodermal tumor,1,CONDITION
pnet,1,CONDITION
low-dose radiation therapy,1,RADIOTHERAPY
newly diagnosed average risk medulloblastoma,1,CONDITION
shared decision making,1,OTHER
moderate or severe dementia,1,CONDITION
sdm interview,1,OTHER
tic douloureux,1,CONDITION
craniofacial neuropathic pain,1,CONDITION
memory decline,1,CONDITION
moxibustion therapy,1,OTHER
transdermal vagal stimulation,1,OTHER
light-headedness,1,CONDITION
electrical stimulation of a nerve through a skin of the ear,1,OTHER
locally-advanced or metastatic alk-positive solid tumors,1,CONDITION
anaplastic lymphoma kinase (alk)-positive locally advanced or metastatic solid tumors,1,CONDITION
stimulation of the anterior nucleus of the thalamus,1,OTHER
bilateral stimulation of the anterior nucleus of the thalamus,1,OTHER
secondary generalization,1,CONDITION
refractory to antiepileptic medications,1,CONDITION
gba-associated parkinson's disease,1,CONDITION
parkinson's disease with mutations of the glucocerebrosidase gene,1,CONDITION
postoperative acute pain,1,CONDITION
s-qlb3),1,SURGICAL
tpvb,1,SURGICAL
constraint therapy,1,PHYSICAL
combined unimanual and bimanual intensive therapy,1,PHYSICAL
constraint-induced movement therapy,1,PHYSICAL
constraint and bimanual therapy,1,PHYSICAL
supported employment with behavioral skills training,1,BEHAVIOURAL
employment support with behavioral skills training,1,BEHAVIOURAL
employment support,1,CONTROL
moderate to severe sdb,1,CONDITION
deep brain stimulation (dbs) of the nucleus basalis of meynert,1,OTHER
parkinson's patients,1,CONDITION
"mild cognitive impairment, amnestic subtype",1,CONDITION
deep brain stimulation of the nucleus basalis of meynert,1,OTHER
moderate to severe ad,1,CONDITION
cognitive and functional decline,1,CONDITION
early phase of dementia,1,CONDITION
self-guided web-based interventions,1,OTHER
online self-guided programs,1,OTHER
early hematoma growth,1,CONDITION
spontaneous intra-cerebral/intra-parenchymal hemorrhage,1,CONDITION
temperature modulation,1,OTHER
mild induced hypothermia,1,OTHER
paradoxical embolism,1,CONDITION
patent foramen ovale,1,CONDITION
recurrent embolic stroke,1,CONDITION
pfo,1,CONDITION
starflex® device,1,OTHER
conformal radiotherapy,1,RADIOTHERAPY
low-grade gliomas,1,CONDITION
gliomas,1,CONDITION
optic nerve neuropathy,1,CONDITION
optic neuropathies,1,CONDITION
gabapentin enacarbil,1,DRUG
gen,1,DRUG
prevention of ischemic stroke and cognition decline,1,OTHER
arrhythmia,1,CONDITION
24-hour simultaneous recorder of electrocardiograph and electroencephalography,1,OTHER
coronary bypass surgery,1,CONDITION
perioperative arrhythmia,1,CONDITION
cerebral embolism,1,CONDITION
pci,1,CONDITION
post-cabg neurological complications,1,CONDITION
paroxysmal arrhythmia,1,CONDITION
whole-body vibration,1,OTHER
poststroke hemiplegia,1,CONDITION
left atrial appendage occluders,1,OTHER
nonvalvular atrial fibrillation,1,CONDITION
preclinical ad,1,CONDITION
virtual reality games,1,OTHER
game rehabilitation,1,OTHER
upper extremity dysfunction,1,CONDITION
cala one device,1,OTHER
transcutaneous afferent patterned stimulation,1,OTHER
no intervention,1,CONTROL
constant exotropia,1,CONDITION
task specific training,1,PHYSICAL
sit-to-stand protocol,1,PHYSICAL
sit-to-stand,1,PHYSICAL
educational intervention,1,BEHAVIOURAL
stretching-and-toning,1,CONTROL
tyrosine kinase inhibitor,1,DRUG
cholinesterase inhibitor,1,DRUG
mild-to-moderate alzheimer's disease,1,CONDITION
visual field restoration,1,OTHER
stimulus,1,OTHER
hemianopsic,1,CONDITION
hemianopsia,1,CONDITION
inflammatory atheromatous plaque,1,CONDITION
inflammatory atheromatous plaques,1,CONDITION
atheromatous plaques,1,CONDITION
intracranial trauma,1,CONDITION
screening,1,BEHAVIOURAL
brief motivational interview,1,BEHAVIOURAL
referral for treatment,1,BEHAVIOURAL
subthalamic nucleus stimulation,1,OTHER
deep brain stimulation of the subthalamic nucleus,1,OTHER
aponeurotic stimulation,1,OTHER
movement slowness,1,CONDITION
stimulation of soft tissues (aponeurosis) of upper limb muscles,1,OTHER
diacutaneous fibrolysis,1,OTHER
aponeurotic manipulation of shoulder muscles,1,OTHER
almonds,1,OTHER
"raw, shelled, unsalted almonds",1,OTHER
pretzels,1,CONTROL
pre-diabetes,1,CONDITION
severely subacute stroke,1,CONDITION
nacl,1,DRUG
chronic jaw muscle myalgia,1,CONDITION
tetraplegia,1,CONDITION
vasotec,1,DRUG
heart attack,1,CONDITION
neurogenic osteoporosis,1,CONDITION
low impact bone fractures,1,CONDITION
osteoporosis,1,CONDITION
low impact fractures,1,CONDITION
low impact fracture,1,CONDITION
osteoporosis-related fractures,1,CONDITION
bone loss,1,CONDITION
neuromuscular electrical stimulation resistance training,1,PHYSICAL
augmented reality based neuronavigation system,1,OTHER
augmented reality (ar) based neuronavigation system,1,OTHER
brain neoplasm,1,CONDITION
cerebral vascular disease,1,CONDITION
conventional intraoperative navigation system,1,CONTROL
guanidinoacetic acid,1,DRUG
creatine deficit,1,CONDITION
guanidinoacetate,1,DRUG
action observation,1,OTHER
observation of actions,1,OTHER
im,1,OTHER
ao,1,OTHER
mirror therapy,1,OTHER
nmes in front of the mirror,1,OTHER
mirror therapy alone,1,CONTROL
nmes alone,1,CONTROL
extracorporeal shock wave therapy,1,OTHER
radial extracorporeal shock wave therapy,1,OTHER
robot rehabilitation exercise training,1,PHYSICAL
robotic stroke therapy,1,PHYSICAL
robotic rehabilitation,1,PHYSICAL
robotic rehabilitation training,1,PHYSICAL
parkinsonian primary pain,1,CONDITION
community based mental health care,1,OTHER
severe and enduring mental ill health,1,CONDITION
music-supported therapy,1,CONTROL
music supported therapy,1,CONTROL
ot,1,CONTROL
parkinson's spectrum,1,CONDITION
motor symptoms,1,CONDITION
intrathoracic pressure regulator,1,OTHER
altered intracranial elastance,1,CONDITION
comprehensive augmented and virtual reality,1,OTHER
augmented and virtual reality-based rehabilitation programs,1,OTHER
td,1,CONDITION
home blood pressure monitor,1,OTHER
abilify,1,DRUG
risperdalâ,1,DRUG
constaâ,1,DRUG
abilifyâ,1,DRUG
post dural puncture headache,1,CONDITION
joint hypermobility,1,CONDITION
postspinal headache,1,CONDITION
pelvic floor versus abdominal muscle exercises,1,PHYSICAL
sleep disruption,1,CONDITION
sleep disturbance,1,CONDITION
clinical pharmacist-led intervention,1,OTHER
cerebrovascular disease,1,CONDITION
clinical pharmacist disease management program,1,OTHER
non-cardioembolic ischemic stroke,1,CONDITION
clinical pharmacist-led disease management intervention,1,OTHER
clinical pharmacy cardiac risk service,1,OTHER
cpcrs,1,OTHER
memory complaint,1,CONDITION
mild cognitive decline,1,CONDITION
aneurysmal subarachnoid hemorrhage,1,CONDITION
moderate severity vasospasm,1,CONDITION
magnesium stearate,1,DRUG
"music-based, rhythm-modulating wearable sensor system",1,OTHER
"music, tailored to the participant's cadence",1,OTHER
tissue adhesive material,1,SURGICAL
suture,1,SURGICAL
wound,1,CONDITION
suture-based wound closure,1,SURGICAL
tissue adhesive-based wound closure,1,SURGICAL
two-component skin adhesive glubran tiss 2,1,SURGICAL
scar,1,CONDITION
divergent squint,1,CONDITION
strabismus surgery,1,SURGICAL
assistive therapy,1,OTHER
exercise robotics,1,PHYSICAL
neurodevelopmental hemiparesis,1,CONDITION
bimanual upper limb training program,1,PHYSICAL
gaming technology,1,OTHER
motion tracking controllers,1,OTHER
visual feedback,1,OTHER
rehabilitative learning tools,1,PHYSICAL
acutely psychotic,1,CONDITION
meningeal syndromes,1,CONDITION
stable sensorineural hearing loss,1,CONDITION
stable snhl,1,CONDITION
robotic exoskeletons,1,PHYSICAL
impaired mobility,1,CONDITION
adeno-associated virus serotype 2 [aav2]-neurturin[ntn],1,OTHER
in vivo aav2 mediated delivery of the gene encoding ntn,1,OTHER
copaxone(r),1,DRUG
primary central nervous system tumors,1,CONDITION
rehabilitation robot,1,PHYSICAL
sham tdcs,1,CONTROL
robot training,1,PHYSICAL
chronic neuropathic wounds,1,CONDITION
diabetic foot ulcers,1,CONDITION
chronic foot ulcers,1,CONDITION
neuropathic,1,CONDITION
diabetes type 2.,1,CONDITION
intellectual disability,1,CONDITION
dnhs technique,1,OTHER
deep dry needling of myofascial trigger points,1,OTHER
hypertonia,1,CONDITION
chronic cerebral vascular accident,1,CONDITION
e2007,1,DRUG
virtual reality mediated neurodynamic exercises,1,PHYSICAL
virtual reality-mediated exercise program,1,PHYSICAL
virtual reality-mediated therapeutic exercise program,1,PHYSICAL
classical exercise programs,1,CONTROL
tendon and nerve gliding exercises,1,PHYSICAL
non-immersive virtual reality systems,1,OTHER
classical exercise program,1,CONTROL
carpal tunnel release,1,CONDITION
carpal tunnel release surgery,1,CONDITION
marcaine,1,DRUG
lifestyle intervention,1,BEHAVIOURAL
lifestyle changes,1,BEHAVIOURAL
early-stage alzheimer's disease,1,CONDITION
progressive refractory meningiomas,1,CONDITION
aggressive growing meningiomas resistant to multiple surgeries and radiotherapy,1,CONDITION
grade ii-iii meningiomas,1,CONDITION
grade iii meningioma,1,CONDITION
meningioma,1,CONDITION
aggressive and recurrent meningiomas,1,CONDITION
aggressive and refractory meningiomas,1,CONDITION
chronic hypercapnic respiratory insufficiency,1,CONDITION
obesity hypoventilation syndrome,1,CONDITION
non-invasive ventilation therapy,1,OTHER
ventilator therapy,1,OTHER
ventilator´s therapy,1,OTHER
eenm,1,OTHER
hemiparesis spastic,1,CONDITION
spastic hemiparetic,1,CONDITION
spastic muscle,1,CONDITION
spastic antagonist muscle,1,CONDITION
music listening,1,OTHER
music interventions,1,OTHER
group-tailored playlist,1,OTHER
radio,1,CONTROL
non-music,1,CONTROL
post infarct,1,CONDITION
rehabilitative approaches,1,OTHER
dysphagia rehabilitative interventions,1,OTHER
pneumonia,1,CONDITION
smartphone application,1,OTHER
mobile application,1,OTHER
"adaptive, tailored content targeting remediation of cognitive distortions",1,OTHER
adaptive application,1,OTHER
standard product,1,CONTROL
peripheral neuromodulation,1,OTHER
nerve stimulation interventions,1,OTHER
neurogenic (spinal cord injury) or non-neurogenic dysfunction,1,CONDITION
aerobic resistance training,1,PHYSICAL
online exercise video rehabilitation program,1,PHYSICAL
aerobic and resistance training using a latex resistance band,1,PHYSICAL
thera band® elastic band,1,PHYSICAL
aerobic exercise videos,1,PHYSICAL
vascular disease of the supra-aortic vessels,1,CONDITION
itraconazole,1,DRUG
sana treatment,1,OTHER
sana device,1,OTHER
active device,1,OTHER
transcutaneous auricular vagus nerve stimulation,1,OTHER
active transcutaneous auricular vagus nerve stimulation,1,OTHER
post-prandial hypotension,1,CONDITION
synucleinopathies,1,CONDITION
dementia with lewy bodies,1,CONDITION
sleep attacks,1,CONDITION
percutaneous biopsy of livers,1,OTHER
neurological death,1,CONDITION
percutaneous liver biopsy,1,OTHER
brain death,1,CONDITION
severe tbi,1,CONDITION
standard normothermic management,1,CONTROL
tissue plasminogen activator,1,CONTROL
sensory stimulation program,1,OTHER
severely brain injured,1,CONDITION
standardised sensory stimulation,1,OTHER
occuaptional therapy,1,OTHER
sensory stimulation,1,OTHER
sensory modalities assessment and rehabilitation technique,1,OTHER
smart,1,OTHER
